Constitutive	O
activation	O
of	O
different	O
Jak	B-protein
tyrosine	I-protein
kinases	I-protein
in	O
human	B-protein
T	I-protein
cell	I-protein
leukemia	I-protein
virus	I-protein
type	I-protein
1	I-protein
(	I-protein
HTLV-1	I-protein
)	I-protein
tax	I-protein
protein	I-protein
or	O
virus-transformed	B-cell_line
cells	I-cell_line
.	O

HTLV-1	O
infection	O
causes	O
an	O
adult	O
T	O
cell	O
leukemia	O
in	O
humans	O
.	O

The	O
viral	B-protein
encoded	I-protein
protein	I-protein
tax	B-protein
,	O
is	O
thought	O
to	O
play	O
an	O
important	O
role	O
in	O
oncogenesis	O
.	O

Our	O
previous	O
data	O
obtained	O
from	O
a	O
tax	B-protein
transgenic	O
mouse	O
model	O
revealed	O
that	O
tax	B-protein
transforms	O
mouse	B-cell_type
fibroblasts	I-cell_type
but	O
not	O
thymocytes	B-cell_type
,	O
despite	O
comparable	O
levels	O
of	O
tax	B-protein
expression	O
in	O
both	O
tissues	O
.	O

Constitutive	O
tyrosine	O
phosphorylation	O
of	O
a	O
130-kD	B-protein
protein	I-protein
(	O
s	O
)	O
was	O
observed	O
in	O
the	O
tax	B-protein
transformed	B-cell_line
fibroblast	I-cell_line
B	I-cell_line
line	I-cell_line
and	O
in	O
HTLV-1	B-cell_line
transformed	I-cell_line
human	I-cell_line
lymphoid	I-cell_line
lines	I-cell_line
,	O
but	O
not	O
in	O
thymocytes	B-cell_type
from	O
Thy-tax	O
transgenic	O
mice	O
.	O

Phosphotyrosine	O
immunoprecipitation	O
followed	O
by	O
Western	O
blot	O
analysis	O
with	O
a	O
set	O
of	O
Jak	B-protein
kinase	I-protein
specific	I-protein
antibodies	I-protein
,	O
identified	O
p130	O
as	O
Jak2	B-protein
in	O
the	O
tax	B-protein
transformed	O
mouse	B-cell_line
fibroblastic	I-cell_line
cell	I-cell_line
line	I-cell_line
and	O
Jak3	B-protein
in	O
HTLV-1	B-cell_line
transformed	I-cell_line
human	I-cell_line
T	I-cell_line
cell	I-cell_line
lines	I-cell_line
.	O

Phosphorylation	O
of	O
Jak2	B-protein
in	O
tax	B-cell_line
transformed	I-cell_line
cells	I-cell_line
resulted	O
from	O
high	O
expression	O
of	O
IL-6	O
.	O

Tyrosine	O
phosphorylation	O
of	O
this	O
protein	O
could	O
also	O
be	O
induced	O
in	O
Balb/c3T3	B-cell_line
cells	I-cell_line
using	O
a	O
supernatant	O
from	O
the	O
B	B-cell_line
line	I-cell_line
,	O
which	O
was	O
associated	O
with	O
induction	O
of	O
cell	O
proliferation	O
.	O

Both	O
phosphorylation	O
and	O
proliferation	O
were	O
inhibited	O
by	O
IL-6	B-protein
neutralizing	I-protein
antibodies	I-protein
.	O

Constitutive	O
phosphorylation	O
of	O
Jak	B-protein
kinases	I-protein
may	O
facilitate	O
tumor	O
growth	O
in	O
both	O
HTLV-1	B-cell_type
infected	I-cell_type
human	I-cell_type
T	I-cell_type
cells	I-cell_type
and	O
the	O
transgenic	O
mouse	O
model	O
.	O

Constitutive	NULL
Activation	NULL
of	NULL
Different	NULL
Jak	NULL
Tyrosine	NULL
Kinases	NULL
in	NULL
Human	NULL
T	NULL
Cell	NULL
Leukemia	NULL
Virus	NULL
Type	NULL
1	NULL
(	NULL
HTLV-1	NULL
)	NULL
Tax	NULL
Protein	NULL
or	NULL
Virus-transformed	NULL
Cells	NULL
Xiao	NULL
Xu	NULL
,	NULL
*	NULL
Shin-Heh	NULL
Kang	NULL
,	NULL
*	NULL
Olaf	NULL
Heidenreich	NULL
,	NULL
*	NULL
Michelle	NULL
Okerholm	NULL
,	NULL
*	NULL
John	NULL
J.	NULL
O'Shea	NULL
,	NULL
*	NULL
and	NULL
Michael	NULL
I.	NULL
Nerenberg*	NULL
*Department	NULL
of	NULL
Molecular	NULL
and	NULL
Experimental	NULL
Medicine	NULL
,	NULL
The	NULL
Scripps	NULL
Research	NULL
Institute	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
California	NULL
92037	NULL
;	NULL
and	NULL
*Leukocyte	NULL
Cell	NULL
Biology	NULL
Section	NULL
,	NULL
Laboratory	NULL
of	NULL
Experimental	NULL
Immunology	NULL
,	NULL
National	NULL
Cancer	NULL
Institute	NULL
,	NULL
FCRDC	NULL
,	NULL
Frederick	NULL
,	NULL
Maryland	NULL
21702	NULL
Abstract	NULL
HTLV-1	NULL
infection	NULL
causes	NULL
an	NULL
adult	NULL
T	NULL
cell	NULL
leukemia	NULL
in	NULL
hu-mans	NULL
.	NULL

The	NULL
viral	NULL
encoded	NULL
protein	NULL
tax	NULL
,	NULL
is	NULL
thought	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
oncogenesis	NULL
.	NULL

Our	NULL
previous	NULL
data	NULL
obtained	NULL
from	NULL
a	NULL
tax	NULL
transgenic	NULL
mouse	NULL
model	NULL
revealed	NULL
that	NULL
tax	NULL
transforms	NULL
mouse	NULL
fibroblasts	NULL
but	NULL
not	NULL
thymocytes	NULL
,	NULL
despite	NULL
comparable	NULL
levels	NULL
of	NULL
tax	NULL
expression	NULL
in	NULL
both	NULL
tissues	NULL
.	NULL

Constitutive	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
a	NULL
130-kD	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
tax	NULL
transformed	NULL
fibroblast	NULL
B	NULL
line	NULL
and	NULL
in	NULL
HTLV-1	NULL
transformed	NULL
human	NULL
lymphoid	NULL
lines	NULL
,	NULL
but	NULL
not	NULL
in	NULL
thymocytes	NULL
from	NULL
Thy-tax	NULL
transgenic	NULL
mice	NULL
.	NULL

Phosphotyrosine	NULL
im-munoprecipitation	NULL
followed	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
with	NULL
a	NULL
set	NULL
of	NULL
Jak	NULL
kinase	NULL
specific	NULL
antibodies	NULL
,	NULL
identified	NULL
p130	NULL
as	NULL
Jak2	NULL
in	NULL
the	NULL
tax	NULL
transformed	NULL
mouse	NULL
fibroblastic	NULL
cell	NULL
line	NULL
and	NULL
Jak3	NULL
in	NULL
HTLV-1	NULL
transformed	NULL
human	NULL
T	NULL
cell	NULL
lines	NULL
.	NULL

Phosphorylation	NULL
of	NULL
Jak2	NULL
in	NULL
tax	NULL
transformed	NULL
cells	NULL
resulted	NULL
from	NULL
high	NULL
expression	NULL
of	NULL
IL-6	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
this	NULL
protein	NULL
could	NULL
also	NULL
be	NULL
induced	NULL
in	NULL
Balb/c3T3	NULL
cells	NULL
using	NULL
a	NULL
supernatant	NULL
from	NULL
the	NULL
B	NULL
line	NULL
,	NULL
which	NULL
was	NULL
associated	NULL
with	NULL
induction	NULL
of	NULL
cell	NULL
proliferation	NULL
.	NULL

Both	NULL
phosphorylation	NULL
and	NULL
proliferation	NULL
were	NULL
inhibited	NULL
by	NULL
IL-6	NULL
neutralizing	NULL
antibodies	NULL
.	NULL

Constitutive	NULL
phosphorylation	NULL
of	NULL
Jak	NULL
kinases	NULL
may	NULL
facilitate	NULL
tumor	NULL
growth	NULL
in	NULL
both	NULL
HTLV-1	NULL
infected	NULL
human	NULL
T	NULL
cells	NULL
and	NULL
the	NULL
transgenic	NULL
mouse	NULL
model	NULL
.	NULL

(	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

1995	NULL
.	NULL

96:1548-1555	NULL
.	NULL
)	NULL

Key	NULL
words	NULL
:	NULL
Jak	NULL
kinase	NULL
,	NULL
HTLV-1	NULL
«	NULL
+	NULL
IL-6	NULL
+	NULL
proliferation	NULL
«	NULL
NF-KB	NULL
Introduction	NULL
Human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HTLV-1	NULL
)	NULL
is	NULL
the	NULL
etiologic	NULL
agent	NULL
of	NULL
adult	NULL
T	NULL
cell	NULL
leukemia	NULL
(	NULL
ATL	NULL
)	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
and	NULL
an	NULL
HTLV-1	NULL
associated	NULL
neurological	NULL
disorder	NULL
,	NULL
called	NULL
tropical	NULL
spastic	NULL
parapa-resis	NULL
or	NULL
HTLV-1-associated	NULL
myelopathy	NULL
(	NULL
TSP/HAM	NULL
)	NULL
(	NULL
3-4	NULL
)	NULL
.	NULL

Mechanisms	NULL
by	NULL
which	NULL
HTLV-1	NULL
immortalizes	NULL
T	NULL
lymphocytes	NULL
are	NULL
not	NULL
well	NULL
understood	NULL
.	NULL

The	NULL
virus	NULL
encoded	NULL
transcriptional	NULL
activator	NULL
protein	NULL
tax	NULL
,	NULL
is	NULL
considered	NULL
a	NULL
crucial	NULL
factor	NULL
in	NULL
tumorigenesis	NULL
.	NULL

Tax	NULL
activates	NULL
both	NULL
CREB/ATF	NULL
and	NULL
NF-KB	NULL
transcriptional	NULL
pathways	NULL
(	NULL
5	NULL
)	NULL
.	NULL

The	NULL
CREB/ATF	NULL
pathway	NULL
is	NULL
particularly	NULL
crucial	NULL
for	NULL
regulation	NULL
of	NULL
the	NULL
viral	NULL
promoter	NULL
.	NULL

Activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
leads	NULL
to	NULL
Address	NULL
correspondence	NULL
to	NULL
Michael	NULL
I.	NULL
Nerenberg	NULL
,	NULL
M.D	NULL
.	NULL

,	NULL
CAL-1	NULL
,	NULL
Department	NULL
of	NULL
Molecular	NULL
and	NULL
Experimental	NULL
Medicine	NULL
,	NULL
10666	NULL
North	NULL
Torrey	NULL
Pines	NULL
Road	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
92037	NULL
.	NULL

Phone	NULL
:	NULL
619-554-7064	NULL
;	NULL
FAX	NULL
:	NULL
619-554-6465	NULL
;	NULL
e-mail	NULL
:	NULL
michaeln	NULL
@	NULL
risesm.scripps.edu	NULL
Received	NULL
for	NULL
publication	NULL
2	NULL
March	NULL
1995	NULL
and	NULL
accepted	NULL
in	NULL
revised	NULL
form	NULL
11	NULL
May	NULL
1995	NULL
.	NULL

1	NULL
.	NULL

Abbreviation	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
HTLV-1	NULL
,	NULL
human	NULL
T	NULL
cell	NULL
tropical	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Clinical	NULL
Investigation	NULL
,	NULL
Inc.	NULL
Volume	NULL
96	NULL
,	NULL
September	NULL
1995	NULL
,	NULL
1548-1555	NULL
1548	NULL
Xu	NULL
et	NULL
al	NULL
.	NULL

disregulation	NULL
of	NULL
numerous	NULL
cytokine	NULL
genes	NULL
including	NULL
IL-2/IL-2Ra	NULL
,	NULL
IL-3	NULL
,	NULL
IL-4	NULL
,	NULL
GM-CSF	NULL
,	NULL
TNF-a	NULL
,	NULL
TGF-	NULL
$	NULL
,	NULL
and	NULL
IL-6	NULL
(	NULL
6-9	NULL
)	NULL
.	NULL

Pervasive	NULL
up-regulation	NULL
of	NULL
these	NULL
cytokines	NULL
may	NULL
favor	NULL
early	NULL
growth	NULL
of	NULL
infected	NULL
and	NULL
neighboring	NULL
cells	NULL
and	NULL
eventually	NULL
encourage	NULL
transformation	NULL
of	NULL
infected	NULL
cells	NULL
.	NULL

As	NULL
demonstrated	NULL
for	NULL
HTLV-1-transformed	NULL
human	NULL
T	NULL
cells	NULL
,	NULL
tax	NULL
expressing	NULL
murine	NULL
fibroblasts	NULL
obtained	NULL
from	NULL
transgenic	NULL
mice	NULL
show	NULL
disregulation	NULL
of	NULL
a	NULL
similar	NULL
set	NULL
of	NULL
cytokine	NULL
genes	NULL
as	NULL
a	NULL
consequence	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
.	NULL

This	NULL
leads	NULL
to	NULL
fibroblastic	NULL
tumors	NULL
in	NULL
tax	NULL
transgenic	NULL
mouse	NULL
models	NULL
.	NULL

Growth	NULL
of	NULL
both	NULL
tax	NULL
transformed	NULL
fibroblasts	NULL
and	NULL
HTLV-1-transformed	NULL
human	NULL
lymphocytes	NULL
can	NULL
be	NULL
blocked	NULL
by	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
but	NULL
not	NULL
tax	NULL
expression	NULL
(	NULL
11	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
constitutive	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
crucial	NULL
for	NULL
maintenance	NULL
of	NULL
the	NULL
transformed	NULL
cell	NULL
growth	NULL
.	NULL

Many	NULL
NF-	NULL
«	NULL
B-regulated	NULL
soluble	NULL
growth	NULL
factors	NULL
and	NULL
cytokines	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
autocrine	NULL
and	NULL
paracrine	NULL
growth	NULL
promoting	NULL
loops	NULL
.	NULL

IL-6	NULL
,	NULL
GM-CSF	NULL
,	NULL
and	NULL
IL-2	NULL
induce	NULL
either	NULL
dimerization	NULL
of	NULL
the	NULL
``	NULL
*P	NULL
``	NULL
signal	NULL
transducing	NULL
receptor	NULL
component	NULL
gp130	NULL
with	NULL
itself	NULL
(	NULL
IL-6	NULL
and	NULL
GM-CSF	NULL
)	NULL
(	NULL
12-14	NULL
)	NULL
or	NULL
dimerization	NULL
of	NULL
IL-2R	NULL
$	NULL
3-y	NULL
,	NULL
(	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
IL-7	NULL
and	NULL
IL-9	NULL
)	NULL
(	NULL
15-19	NULL
)	NULL
.	NULL

Dimerization	NULL
of	NULL
receptor	NULL
components	NULL
,	NULL
in	NULL
turn	NULL
activate	NULL
members	NULL
of	NULL
the	NULL
JAK/TyK	NULL
family	NULL
of	NULL
receptor-associated	NULL
tyrosine	NULL
kinases	NULL
.	NULL

These	NULL
consist	NULL
of	NULL
Jak1	NULL
,	NULL
Jak2	NULL
,	NULL
Jak3	NULL
,	NULL
and	NULL
Tyk2	NULL
all	NULL
with	NULL
sizes	NULL
of	NULL
~	NULL
130	NULL
kD	NULL
(	NULL
12-19	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
show	NULL
that	NULL
a	NULL
130-kD	NULL
cellular	NULL
protein	NULL
is	NULL
constitutively	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
both	NULL
Tax	NULL
transformed	NULL
mouse	NULL
fibroblasts	NULL
and	NULL
HTLV-1	NULL
transformed	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

This	NULL
protein	NULL
was	NULL
identified	NULL
as	NULL
Jak2	NULL
in	NULL
tax	NULL
transformed	NULL
fibroblasts	NULL
and	NULL
Jak3	NULL
in	NULL
HTLV-1	NULL
transformed	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Constitutive	NULL
activation	NULL
of	NULL
Jak	NULL
kinases	NULL
was	NULL
a	NULL
consequence	NULL
of	NULL
tax	NULL
mediated	NULL
disregulation	NULL
of	NULL
IL-6	NULL
in	NULL
the	NULL
fibroblasts	NULL
.	NULL

Methods	NULL
Cells	NULL
.	NULL

Cell	NULL
lines	NULL
used	NULL
included	NULL
Balb/c3T3	NULL
;	NULL
the	NULL
HTLV-1	NULL
tax	NULL
transformed	NULL
B	NULL
line	NULL
(	NULL
11	NULL
)	NULL
,	NULL
cloned	NULL
from	NULL
fibrosarcomas	NULL
occurring	NULL
in	NULL
HTLV-1-LTR	NULL
Tax	NULL
transgenic	NULL
mice	NULL
(	NULL
10	NULL
)	NULL
,	NULL
HTLV-1	NULL
transformed	NULL
human	NULL
lymphocyte	NULL
lines	NULL
:	NULL
MT2	NULL
,	NULL
MT4	NULL
(	NULL
obtained	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
,	NULL
ATCC	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
,	NULL
HUT1O02	NULL
,	NULL
C91-pl	NULL
,	NULL
C91-	NULL
,	NULL
and	NULL
C81-66	NULL
(	NULL
provided	NULL
by	NULL
Dr.	NULL
K.	NULL
McGuire	NULL
,	NULL
San	NULL
Diego	NULL
State	NULL
University	NULL
)	NULL
,	NULL
and	NULL
a	NULL
mature	NULL
human	NULL
T	NULL
cell	NULL
lymphoma	NULL
cell	NULL
line	NULL
(	NULL
Jurkat	NULL
)	NULL
obtained	NULL
from	NULL
ATCC	NULL
.	NULL

Mouse	NULL
thymocytes	NULL
were	NULL
isolated	NULL
from	NULL
one	NULL
and	NULL
a	NULL
half	NULL
month	NULL
old	NULL
Thy-tax	NULL
transgenic	NULL
(	NULL
20	NULL
)	NULL
or	NULL
normal	NULL
C57/BL6	NULL
mouse	NULL
thymuses	NULL
using	NULL
a	NULL
protocol	NULL
previously	NULL
described	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Antibodies	NULL
.	NULL

Antibodies	NULL
used	NULL
in	NULL
this	NULL
study	NULL
were	NULL
rabbit	NULL
anti-NF-	NULL
«	NULL
B	NULL
p50	NULL
and	NULL
p65	NULL
(	NULL
from	NULL
I.	NULL
Verma	NULL
,	NULL
Salk	NULL
Institute	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
rabbit	NULL
anti-Jak1	NULL
or	NULL
Jak2	NULL
(	NULL
UBI	NULL
NY	NULL
)	NULL
,	NULL
rabbit	NULL
anti-Jak3	NULL
(	NULL
from	NULL
O'Shea	NULL
,	NULL
NCI	NULL
,	NULL
FCRF	NULL
Frederick	NULL
,	NULL
MD	NULL
)	NULL
,	NULL
mouse	NULL
monoclonal	NULL
anti-phosphotyrosine	NULL
(	NULL
Transduc-tion	NULL
Labs	NULL
)	NULL
,	NULL
mouse	NULL
monoclonal	NULL
anti-IL-6	NULL
(	NULL
2	NULL
antibodies	NULL
obtained	NULL
from	NULL
PharMingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
mouse	NULL
anti-TNF-	NULL
«	NULL
(	NULL
PharMingen	NULL
)	NULL
.	NULL

ELISA	NULL
.	NULL

A	NULL
mouse	NULL
IL-6	NULL
ELISA	NULL
kit	NULL
(	NULL
PharMingen	NULL
)	NULL
was	NULL
used	NULL
to	NULL
measure	NULL
secretion	NULL
of	NULL
IL-6	NULL
in	NULL
B	NULL
line	NULL
cell	NULL
culture	NULL
supernatants	NULL
collected	NULL
at	NULL
different	NULL
time	NULL
intervals	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
and	NULL
immunoprecipitation	NULL
.	NULL

Westem	NULL
blotting	NULL
o	NULL
y-£	NULL
£3	NULL
ﬁf	NULL
'	NULL
ﬁ	NULL
m	NULL
~	NULL
4	NULL
3	NULL
205	NULL
kD	NULL
-	NULL
``	NULL
``	NULL
j	NULL
p130	NULL
Gc	NULL
«	NULL
116	NULL
kD	NULL
-	NULL
#	NULL
80	NULL
kD	NULL
49	NULL
kD	NULL
-	NULL
;	NULL
37	NULL
p-	NULL
0	NULL
_	NULL
__	NULL
*I	NULL
``	NULL
a	NULL
1	NULL
2	NULL
3	NULL
4	NULL
was	NULL
used	NULL
to	NULL
detect	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
and	NULL
p65	NULL
,	NULL
tyrosine	NULL
phosphorylated	NULL
proteins	NULL
and	NULL
Jak	NULL
kinases	NULL
.	NULL

The	NULL
tyrosine	NULL
phosphatase	NULL
inhibitor	NULL
sodium	NULL
orthovani-date	NULL
(	NULL
1	NULL
mM	NULL
)	NULL
,	NULL
was	NULL
added	NULL
to	NULL
the	NULL
lysis	NULL
buffer	NULL
during	NULL
preparation	NULL
of	NULL
the	NULL
cytosolic	NULL
extracts	NULL
.	NULL

In	NULL
sequential	NULL
Immunoprecipitate/	NULL
Western	NULL
analyses	NULL
,	NULL
detection	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
was	NULL
performed	NULL
by	NULL
immunoprecipi-tation	NULL
first	NULL
,	NULL
using	NULL
the	NULL
phosphotyrosine	NULL
specific	NULL
antibody	NULL
.	NULL

Briefly	NULL
,	NULL
50	NULL
ug	NULL
of	NULL
cytosolic	NULL
protein	NULL
was	NULL
incubated	NULL
with	NULL
1	NULL
l	NULL
of	NULL
mouse	NULL
anti-phosphotyrosine	NULL
antibody	NULL
in	NULL
RIPA	NULL
buffer	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
1	NULL
h.	NULL
The	NULL
antibodies	NULL
were	NULL
captured	NULL
by	NULL
incubation	NULL
with	NULL
protein	NULL
G	NULL
agarose	NULL
beads	NULL
(	NULL
Calbiochem	NULL
Corp.	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
for	NULL
another	NULL
hour	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
followed	NULL
by	NULL
washing	NULL
four	NULL
times	NULL
with	NULL
TBS	NULL
(	NULL
0.01	NULL
M	NULL
Tris	NULL
pH	NULL
7.5	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
0.05	NULL
%	NULL
Tween	NULL
20	NULL
)	NULL
.	NULL

Precipitated	NULL
materials	NULL
were	NULL
eluted	NULL
by	NULL
boiling	NULL
in	NULL
SDS	NULL
sample	NULL
buffer	NULL
and	NULL
subjected	NULL
to	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
Jak	NULL
specific	NULL
antibodies	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Total	NULL
reaction	NULL
volume	NULL
was	NULL
25	NULL
ul	NULL
which	NULL
included	NULL
5	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
,	NULL
1	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dl-dC	NULL
)	NULL
,	NULL
0.2	NULL
ng	NULL
of	NULL
°P	NULL
end	NULL
labeled	NULL
NF-	NULL
«	NULL
B	NULL
probe	NULL
(	NULL
AGCTTCAACAGAGGGGACTTITTCCG-AGAGGCTCGAG	NULL
)	NULL
(	NULL
10°	NULL
cpm/ug	NULL
DNA	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
buffer	NULL
was	NULL
10	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
75	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
7	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
.	NULL

After	NULL
20	NULL
min	NULL
of	NULL
incubation	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
the	NULL
reactions	NULL
were	NULL
loaded	NULL
on	NULL
a	NULL
5	NULL
%	NULL
acrylamide	NULL
gel	NULL
and	NULL
run	NULL
in	NULL
0.5	NULL
%	NULL
Tris-borate-EDTA	NULL
(	NULL
TBE	NULL
)	NULL
buffer	NULL
at	NULL
4°C	NULL
.	NULL

For	NULL
antibody	NULL
mediated	NULL
super	NULL
shifts	NULL
,	NULL
specific	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
or	NULL
p65	NULL
antibody	NULL
(	NULL
2	NULL
ug	NULL
)	NULL
was	NULL
first	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
20	NULL
min	NULL
.	NULL

followed	NULL
by	NULL
EMSA	NULL
analysis	NULL
as	NULL
above	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
.	NULL

Poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
mRNA	NULL
was	NULL
isolated	NULL
from	NULL
B	NULL
line	NULL
cells	NULL
or	NULL
Balb/c	NULL
3T3	NULL
cells	NULL
using	NULL
the	NULL
FastTrack	NULL
method	NULL
(	NULL
Invitrogen	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Electrophoresis	NULL
was	NULL
followed	NULL
by	NULL
transfer	NULL
onto	NULL
nylon	NULL
mem-branes	NULL
.	NULL

Hybridization	NULL
detection	NULL
was	NULL
with	NULL
a	NULL
PCR-generated	NULL
IL-6R	NULL
probe	NULL
.	NULL

Primers	NULL
were	NULL
5	NULL
CCCTGCCCACATTCCTGGT	NULL
3	NULL
'	NULL
;	NULL
5	NULL
'	NULL
TACGGTATT-GTCAGACCC	NULL
3	NULL
'	NULL
.	NULL

The	NULL
same	NULL
blot	NULL
was	NULL
re-hybridized	NULL
with	NULL
actin	NULL
probe	NULL
to	NULL
control	NULL
for	NULL
mRNA	NULL
loading	NULL
.	NULL

[	NULL
°H	NULL
]	NULL
Thymidine	NULL
incorporation	NULL
assay	NULL
.	NULL

(	NULL
21	NULL
)	NULL
Both	NULL
B	NULL
line	NULL
cells	NULL
and	NULL
Balb/c	NULL
3T3	NULL
cells	NULL
were	NULL
plated	NULL
in	NULL
24-well	NULL
plates	NULL
for	NULL
48	NULL
h	NULL
in	NULL
DME	NULL
(	NULL
GIBCO/BRL	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
plus	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
DME	NULL
(	NULL
GIBCO/BRL	NULL
)	NULL
until	NULL
80	NULL
%	NULL
confluent	NULL
.	NULL

Cells	NULL
were	NULL
subjected	NULL
to	NULL
serum	NULL
starvation	NULL
for	NULL
24	NULL
h	NULL
by	NULL
replacing	NULL
the	NULL
media	NULL
with	NULL
serum	NULL
free	NULL
DME	NULL
.	NULL

To	NULL
measure	NULL
cell	NULL
proliferation	NULL
,	NULL
[	NULL
°H	NULL
]	NULL
thymidine	NULL
(	NULL
1	NULL
meui/ml	NULL
)	NULL
was	NULL
added	NULL
to	NULL
serum	NULL
starved	NULL
Balb/c3T3	NULL
cells	NULL
,	NULL
which	NULL
were	NULL
used	NULL
to	NULL
monitor	NULL
cell	NULL
prolifer-ative	NULL
response	NULL
.	NULL

Undiluted	NULL
serum	NULL
free	NULL
B	NULL
line	NULL
cell	NULL
supernatants	NULL
or	NULL
mouse	NULL
recombinant	NULL
IL-6	NULL
(	NULL
Genzyme	NULL
Corp.	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
;	NULL
4	NULL
ng/ml	NULL
)	NULL
were	NULL
used	NULL
t	NULL
H	NULL
P	NULL
»	NULL
0	NULL
o	NULL
a	NULL
E	NULL
C	NULL
2	NULL
3	NULL
B	NULL
thymocytes	NULL
tax	NULL
Figure	NULL
1	NULL
.	NULL

A	NULL
130-kD	NULL
cytoplasmic	NULL
protein	NULL
is	NULL
constitutively	NULL
tyrosine	NULL
phosphorylated	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
of	NULL
cellular	NULL
lysates	NULL
prepared	NULL
from	NULL
B	NULL
line	NULL
cells	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
Balb/c3T3	NULL
cells	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
MT2	NULL
cells	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
Jurkat	NULL
cells	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
and	NULL
thymocytes	NULL
of	NULL
a	NULL
Thy-tax	NULL
transgenic	NULL
mice	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
or	NULL
normal	NULL
C57/BL	NULL
mice	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

15	NULL
ug	NULL
of	NULL
lysate	NULL
was	NULL
used	NULL
for	NULL
each	NULL
lane	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
probed	NULL
with	NULL
anti-phosphotyrosine	NULL
antibody	NULL
.	NULL

The	NULL
tyrosine	NULL
phosphorylated	NULL
p130	NULL
is	NULL
indicated	NULL
.	NULL

as	NULL
sources	NULL
of	NULL
growth	NULL
factors	NULL
.	NULL

Inhibition	NULL
by	NULL
IL-6	NULL
antibody	NULL
was	NULL
performed	NULL
at	NULL
10	NULL
ug/ml	NULL
.	NULL

Two	NULL
independent	NULL
IL-6	NULL
neutralizing	NULL
antibodies	NULL
yielded	NULL
similar	NULL
results	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
after	NULL
24	NULL
h	NULL
and	NULL
all	NULL
assays	NULL
were	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

Experiments	NULL
were	NULL
repeated	NULL
twice	NULL
.	NULL

[	NULL
*H	NULL
]	NULL
thymidine	NULL
incorporation	NULL
was	NULL
measured	NULL
by	NULL
liquid	NULL
scintillation	NULL
counting	NULL
.	NULL

Results	NULL
A	NULL
130-kD	NULL
protein	NULL
is	NULL
constitutively	NULL
phosphorylated	NULL
in	NULL
Tax-transformed	NULL
mouse	NULL
fibroblasts	NULL
and	NULL
in	NULL
HTLV-1	NULL
transformed	NULL
human	NULL
T	NULL
cell	NULL
lines	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
tax	NULL
or	NULL
HTLV-1	NULL
expression	NULL
in	NULL
some	NULL
cell	NULL
lines	NULL
leads	NULL
to	NULL
overexpression	NULL
of	NULL
many	NULL
growth	NULL
factors	NULL
and	NULL
cytokines	NULL
(	NULL
6-9	NULL
)	NULL
.	NULL

Considerable	NULL
evidence	NULL
has	NULL
also	NULL
demonstrated	NULL
that	NULL
induction	NULL
of	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
is	NULL
associated	NULL
with	NULL
growth	NULL
factor	NULL
or	NULL
cyto-kine-mediated	NULL
cell	NULL
proliferation	NULL
.	NULL

To	NULL
evaluate	NULL
the	NULL
role	NULL
of	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
HTLV-1	NULL
virus	NULL
or	NULL
tax	NULL
transforma-tion	NULL
,	NULL
we	NULL
performed	NULL
Western	NULL
blot	NULL
analyses	NULL
on	NULL
several	NULL
different	NULL
cell	NULL
lines	NULL
,	NULL
using	NULL
a	NULL
phosphotyrosine-specific	NULL
antibody	NULL
.	NULL

Interest-ingly	NULL
,	NULL
a	NULL
dominant	NULL
phosphorylated	NULL
protein	NULL
with	NULL
a	NULL
size	NULL
of	NULL
130	NULL
kD	NULL
was	NULL
consistently	NULL
detected	NULL
in	NULL
the	NULL
tax	NULL
transformed	NULL
mouse	NULL
fibroblastic	NULL
cell	NULL
lines	NULL
and	NULL
in	NULL
HTLV-1	NULL
transformed	NULL
human	NULL
T	NULL
lymphocytes	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
lanes	NULL
1	NULL
,	NULL
3	NULL
,	NULL
and	NULL
5	NULL
)	NULL
.	NULL

This	NULL
protein	NULL
was	NULL
also	NULL
shown	NULL
to	NULL
autophosphorylate	NULL
itself	NULL
in	NULL
situ	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
protein	NULL
was	NULL
not	NULL
phosphorylated	NULL
in	NULL
Balb/c	NULL
3T3	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
Jurkat	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
or	NULL
normal	NULL
mouse	NULL
thymocyte	NULL
controls	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
some	NULL
tax	NULL
expressing	NULL
but	NULL
untransformed	NULL
cells	NULL
do	NULL
not	NULL
overproduce	NULL
cytokines	NULL
.	NULL

In	NULL
previous	NULL
studies	NULL
of	NULL
a	NULL
Thy-tax	NULL
model	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
intra-thymic	NULL
tax	NULL
is	NULL
capable	NULL
of	NULL
activating	NULL
the	NULL
HTLV-1	NULL
LTR	NULL
promoter	NULL
(	NULL
20	NULL
)	NULL
,	NULL
presumably	NULL
through	NULL
a	NULL
CREB/ATF	NULL
pathway	NULL
(	NULL
20	NULL
,	NULL
23	NULL
)	NULL
.	NULL

However	NULL
,	NULL
these	NULL
tax	NULL
expressing	NULL
thymocytes	NULL
failed	NULL
to	NULL
express	NULL
increased	NULL
levels	NULL
of	NULL
IL-2R	NULL
,	NULL
IL-2	NULL
,	NULL
IL-6	NULL
,	NULL
GM-CSF	NULL
,	NULL
or	NULL
PDGF	NULL
(	NULL
20	NULL
)	NULL
.	NULL

These	NULL
Thy-tax	NULL
thymocytes	NULL
also	NULL
failed	NULL
to	NULL
show	NULL
phosphorylation	NULL
of	NULL
p130	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
multiple	NULL
individual	NULL
mice	NULL
gave	NULL
the	NULL
same	NULL
result	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
suggested	NULL
that	NULL
p130	NULL
phosphorylation	NULL
,	NULL
and	NULL
cellular	NULL
transformation	NULL
was	NULL
most	NULL
closely	NULL
linked	NULL
to	NULL
the	NULL
ability	NULL
of	NULL
tax	NULL
to	NULL
induce	NULL
cytokines	NULL
.	NULL

Constitutive	NULL
Jak	NULL
Activation	NULL
by	NULL
HTLV-1	NULL
QTax	NULL
and	NULL
Virus	NULL
1549	NULL
w	NULL
0	NULL
=	NULL
>	NULL
-	NULL
8	NULL
@	NULL
©	NULL
g	NULL
~	NULL
x	NULL
€	NULL
2	NULL
-	NULL
5	NULL
>	NULL
mmE—aﬁ	NULL
No-	NULL
wu	NULL
th	NULL
1	NULL
Tax+	NULL
thymocytes	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
Tax	NULL
C	NULL
lymphocytes	NULL
[	NULL
--	NULL
A	NULL
9	NULL
i	NULL
H	NULL
x	NULL
o	NULL
-	NULL
o	NULL
fibroblasts	NULL
S	NULL
+5	NULL
®	NULL
®	NULL
O	NULL
x	NULL
Q	NULL
C	NULL
£	NULL
®	NULL
w	NULL
xz	NULL
EE	NULL
ah	NULL
Pb	NULL
P	NULL
on	NULL
a	NULL
41	NULL
50	NULL
E	NULL
;	NULL
Slits	NULL
l	NULL
Figure	NULL
2	NULL
.	NULL

Activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
different	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
specific	NULL
nuclear	NULL
NF-KB	NULL
binding	NULL
in	NULL
tax	NULL
transformed	NULL
fibroblasts	NULL
(	NULL
B	NULL
line	NULL
)	NULL
.	NULL

An	NULL
Ig-	NULL
«	NULL
B	NULL
ODN	NULL
containing	NULL
the	NULL
consensus	NULL
sequence	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
used	NULL
as	NULL
an	NULL
EMSA	NULL
probe	NULL
.	NULL

Two	NULL
binding	NULL
complexes	NULL
were	NULL
seen	NULL
in	NULL
B	NULL
line	NULL
nuclear	NULL
extracts	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
which	NULL
can	NULL
be	NULL
super	NULL
shifted	NULL
by	NULL
antibodies	NULL
to	NULL
p65	NULL
or	NULL
p50	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

A	NULL
nonspecific	NULL
binding	NULL
complex	NULL
(	NULL
Np	NULL
)	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

(	NULL
B	NULL
)	NULL
EMSA	NULL
in	NULL
different	NULL
cells	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
B	NULL
line	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
Balb/c3T3	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
HTLV-1-transformed	NULL
human	NULL
T	NULL
lymphocytes	NULL
(	NULL
M72	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
Jurkat	NULL
cells	NULL
(	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
cell	NULL
line	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
and	NULL
thymocytes	NULL
from	NULL
a	NULL
tax	NULL
positive	NULL
Thy-tax	NULL
transgenic	NULL
mouse	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
and	NULL
a	NULL
normal	NULL
C57/BL	NULL
mouse	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
nuclear	NULL
extract	NULL
(	NULL
5.0	NULL
ug	NULL
)	NULL
were	NULL
applied	NULL
to	NULL
each	NULL
lane	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
probe	NULL
is	NULL
described	NULL
in	NULL
the	NULL
methods	NULL
section	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
with	NULL
antibodies	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
and	NULL
p65	NULL
.	NULL

Tested	NULL
cell	NULL
lines	NULL
and	NULL
p50	NULL
or	NULL
p65	NULL
protein	NULL
are	NULL
indicated	NULL
.	NULL

Phosphorylation	NULL
of	NULL
p130	NULL
associated	NULL
with	NULL
nuclear	NULL
activation	NULL
of	NULL
NF-KB	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
activating	NULL
CREB/ATF	NULL
family	NULL
mem-bers	NULL
,	NULL
tax	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
a	NULL
potent	NULL
activator	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
pathway	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
cytokines	NULL
best	NULL
associated	NULL
with	NULL
tax	NULL
or	NULL
HTLV-1	NULL
transformation	NULL
are	NULL
NF-	NULL
«	NULL
B	NULL
dependent	NULL
.	NULL

To	NULL
examine	NULL
correlation	NULL
between	NULL
p130	NULL
phosphorylation	NULL
and	NULL
nuclear	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
we	NULL
performed	NULL
EMSA	NULL
analyses	NULL
.	NULL

We	NULL
used	NULL
a	NULL
*P-labeled	NULL
probe	NULL
which	NULL
contains	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
consensus	NULL
sequence	NULL
of	NULL
the	NULL
Ig-kB	NULL
promoter	NULL
and	NULL
has	NULL
been	NULL
demonstrated	NULL
to	NULL
bind	NULL
the	NULL
p50/p65	NULL
heterodimer	NULL
efficiently	NULL
(	NULL
11	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
tax-transformed	NULL
mouse	NULL
fibroblastic	NULL
tumor	NULL
cells	NULL
and	NULL
HTLV-1	NULL
transformed	NULL
human	NULL
T	NULL
cells	NULL
revealed	NULL
constitutive	NULL
nuclear	NULL
binding	NULL
to	NULL
this	NULL
probe	NULL
.	NULL

This	NULL
binding	NULL
could	NULL
be	NULL
super-shifted	NULL
by	NULL
antibodies	NULL
to	NULL
both	NULL
p65	NULL
and	NULL
p50	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
,	NULL
and	NULL
specifically	NULL
competed	NULL
by	NULL
wildtype	NULL
NF-	NULL
«	NULL
B	NULL
ODN	NULL
but	NULL
not	NULL
mutant	NULL
NF-	NULL
«	NULL
B	NULL
ODN	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
neither	NULL
Jurkat	NULL
cells	NULL
,	NULL
thymocytes	NULL
from	NULL
normal	NULL
or	NULL
Thy-tax	NULL
transgenic	NULL
mice	NULL
nor	NULL
Balb/c	NULL
3T3	NULL
cells	NULL
showed	NULL
high	NULL
levels	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
B	NULL
,	NULL
lanes	NULL
2	NULL
,	NULL
4	NULL
,	NULL
5	NULL
,	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Overall	NULL
expression	NULL
levels	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
and	NULL
p65	NULL
were	NULL
the	NULL
same	NULL
in	NULL
all	NULL
cells	NULL
,	NULL
as	NULL
judged	NULL
by	NULL
Western	NULL
blot	NULL
analyses	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
C	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
activation	NULL
of	NULL
NF-kB	NULL
by	NULL
tax	NULL
may	NULL
be	NULL
necessary	NULL
for	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
p130	NULL
.	NULL

Tissue	NULL
specific	NULL
inability	NULL
of	NULL
tax	NULL
to	NULL
activate	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
pathway	NULL
in	NULL
thymocytes	NULL
was	NULL
associated	NULL
with	NULL
failure	NULL
to	NULL
phosphorylate	NULL
p130	NULL
and	NULL
transform	NULL
these	NULL
cells	NULL
.	NULL

IL-6	NULL
secreted	NULL
by	NULL
Tax-transformed	NULL
transgenic	NULL
mouse	NULL
fibroblasts	NULL
,	NULL
induces	NULL
phosphorylation	NULL
of	NULL
p130	NULL
and	NULL
cellular	NULL
proliferation	NULL
.	NULL

As	NULL
shown	NULL
above	NULL
,	NULL
a	NULL
signal	NULL
transduction	NULL
pathway	NULL
activated	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
may	NULL
mediate	NULL
phosphorylation	NULL
of	NULL
p130	NULL
.	NULL

A	NULL
good	NULL
candi-	NULL
1550	NULL
Xu	NULL
et	NULL
al	NULL
.	NULL

date	NULL
for	NULL
a	NULL
mediator	NULL
in	NULL
tax	NULL
transformed	NULL
transgenic	NULL
fibroblasts	NULL
was	NULL
IL-6	NULL
,	NULL
since	NULL
we	NULL
have	NULL
previously	NULL
shown	NULL
its	NULL
expression	NULL
to	NULL
be	NULL
highly	NULL
stimulated	NULL
in	NULL
tax-transformed	NULL
fibroblasts	NULL
(	NULL
11	NULL
,	NULL
24	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
its	NULL
expression	NULL
is	NULL
highly	NULL
NF-	NULL
«	NULL
B	NULL
dependent	NULL
in	NULL
tax	NULL
transformed	NULL
cells	NULL
,	NULL
since	NULL
inhibition	NULL
of	NULL
the	NULL
p65	NULL
component	NULL
of	NULL
NF-kB	NULL
by	NULL
antisense	NULL
oligodeoxynucleotides	NULL
resulted	NULL
in	NULL
profound	NULL
decrease	NULL
of	NULL
IL-6	NULL
expression	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Using	NULL
a	NULL
murine	NULL
specific	NULL
ELISA	NULL
,	NULL
we	NULL
determined	NULL
the	NULL
accumulation	NULL
rate	NULL
of	NULL
IL-6	NULL
in	NULL
culture	NULL
supernatants	NULL
to	NULL
be	NULL
0.2	NULL
ng/ml	NULL
per	NULL
hour	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
A	NULL
)	NULL
.	NULL

IL-6	NULL
expression	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
supernatants	NULL
from	NULL
control	NULL
Balb/c3T3	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
A	NULL
)	NULL
.	NULL

Both	NULL
tax	NULL
transformed	NULL
fibroblasts	NULL
and	NULL
Balb/c3T3	NULL
cells	NULL
expressed	NULL
similar	NULL
levels	NULL
of	NULL
the	NULL
p80	NULL
IL-6	NULL
receptor	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
B	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
both	NULL
should	NULL
be	NULL
equally	NULL
capable	NULL
of	NULL
responding	NULL
to	NULL
IL-6	NULL
.	NULL

To	NULL
establish	NULL
whether	NULL
p130	NULL
phosphorylation	NULL
could	NULL
be	NULL
caused	NULL
by	NULL
secreted	NULL
IL-6	NULL
,	NULL
supernatants	NULL
from	NULL
the	NULL
tax	NULL
transformed	NULL
fibroblast	NULL
(	NULL
B	NULL
line	NULL
)	NULL
cells	NULL
were	NULL
added	NULL
to	NULL
Balb/c3T3	NULL
cell	NULL
cultures	NULL
.	NULL

Within	NULL
1	NULL
h	NULL
,	NULL
p130	NULL
was	NULL
the	NULL
most	NULL
prominent	NULL
protein	NULL
observed	NULL
to	NULL
be	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
Balb/c	NULL
3T3	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

To	NULL
evaluate	NULL
the	NULL
role	NULL
of	NULL
IL-6	NULL
in	NULL
inducing	NULL
phosphorylation	NULL
of	NULL
p130	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
IL-6	NULL
neutralizing	NULL
antibodies	NULL
to	NULL
inhibit	NULL
p130	NULL
phos-	NULL
:	NULL
phorylation	NULL
was	NULL
evaluated	NULL
.	NULL

A	NULL
similar	NULL
class	NULL
and	NULL
concentration	NULL
of	NULL
NF-kB	NULL
p50	NULL
or	NULL
TNF-a	NULL
antibodies	NULL
were	NULL
used	NULL
as	NULL
controls	NULL
.	NULL

Both	NULL
the	NULL
IL-6	NULL
and	NULL
TNF-a	NULL
antibodies	NULL
are	NULL
known	NULL
to	NULL
be	NULL
neutralizing	NULL
and	NULL
are	NULL
extremely	NULL
clean	NULL
when	NULL
analyzed	NULL
by	NULL
Western	NULL
blot	NULL
or	NULL
ELISA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
only	NULL
IL-6	NULL
antibody	NULL
was	NULL
able	NULL
to	NULL
specifically	NULL
block	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
p130	NULL
in	NULL
Balb/c3T3	NULL
cells	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

This	NULL
suggested	NULL
that	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
p130	NULL
was	NULL
largely	NULL
mediated	NULL
by	NULL
solu-	NULL
27	NULL
--	NULL
QO	NULL
--	NULL
_	NULL
B	NULL
line/10	NULL
%	NULL
FCS	NULL
3	NULL
~-~O~	NULL
B	NULL
line/	NULL
0	NULL
%	NULL
FCS	NULL
==~-O-***	NULL
_	NULL
3T3/10	NULL
%	NULL
FCS	NULL
1.54	NULL
8	NULL
'	NULL
]	NULL
a	NULL
a	NULL
8	NULL
80	NULL
D	NULL
4	NULL
bs	NULL
&	NULL
t	NULL
0.57	NULL
(	NULL
J	NULL
{	NULL
mammae	NULL
neenee	NULL
sss	NULL
h	NULL
®	NULL
h	NULL
®	NULL
e	NULL
R	NULL
y	NULL
y	NULL
T	NULL
T	NULL
1	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
(	NULL
days	NULL
)	NULL
ble	NULL
IL-6	NULL
secreted	NULL
by	NULL
tax	NULL
transformed	NULL
fibroblasts	NULL
.	NULL

Indeed	NULL
,	NULL
phosphorylation	NULL
of	NULL
p130	NULL
in	NULL
Balb/c3T3	NULL
could	NULL
be	NULL
equally	NULL
induced	NULL
by	NULL
either	NULL
B	NULL
line	NULL
supernatant	NULL
or	NULL
recombinant	NULL
IL6	NULL
but	NULL
not	NULL
by	NULL
serum	NULL
or	NULL
PMA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
relationship	NULL
between	NULL
IL-6	NULL
induced	NULL
phosphorylation	NULL
of	NULL
p130	NULL
and	NULL
cell	NULL
proliferation	NULL
was	NULL
then	NULL
studied	NULL
.	NULL

[	NULL
°H	NULL
]	NULL
thymidine	NULL
incorporation	NULL
experiments	NULL
were	NULL
performed	NULL
.	NULL

The	NULL
above	NULL
described	NULL
ELISA	NULL
results	NULL
,	NULL
demonstrated	NULL
secretion	NULL
of	NULL
IL-6	NULL
by	NULL
B	NULL
cells	NULL
even	NULL
when	NULL
grown	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
serum	NULL
up	NULL
till	NULL
day	NULL
3	NULL
of	NULL
culture	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
A	NULL
)	NULL
.	NULL

This	NULL
allowed	NULL
stimulation	NULL
to	NULL
be	NULL
measured	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
exogenous	NULL
serum	NULL
.	NULL

Balb/c3T3	NULL
cells	NULL
were	NULL
allowed	NULL
to	NULL
reach	NULL
80	NULL
%	NULL
confluence	NULL
prior	NULL
to	NULL
serum	NULL
starvation	NULL
for	NULL
24	NULL
h.	NULL
Under	NULL
these	NULL
conditions	NULL
,	NULL
cell	NULL
growth	NULL
was	NULL
largely	NULL
arrested	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

When	NULL
either	NULL
the	NULL
serum	NULL
free	NULL
supernatant	NULL
from	NULL
B	NULL
line	NULL
cell	NULL
cultures	NULL
or	NULL
recombinant	NULL
IL6	NULL
were	NULL
added	NULL
,	NULL
[	NULL
°H	NULL
]	NULL
thymidine	NULL
incorporation	NULL
rate	NULL
in	NULL
Balb/c3T3	NULL
cells	NULL
was	NULL
increased	NULL
dramatically	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
5	NULL
)	NULL
.	NULL

This	NULL
increase	NULL
was	NULL
specifically	NULL
inhibited	NULL
by	NULL
IL-6	NULL
neutralizing	NULL
antibody	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
6	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
tax	NULL
induced	NULL
IL-6	NULL
may	NULL
play	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
3T3	NULL
cells+	NULL
B	NULL
supernatant	NULL
B	NULL
0	NULL
1	NULL
3	NULL
6	NULL
(	NULL
br	NULL
)	NULL
P130	NULL
‘	NULL
o	NULL
p	NULL
130	NULL
1eD	NULL
-	NULL
-	NULL
M	NULL
@	NULL
gor	NULL
white	NULL
gham	NULL
le	NULL
kp	NULL
_	NULL
80	NULL
kD	NULL
~~	NULL
@	NULL
in	NULL
sme	NULL
dth	NULL
dilth	NULL
mm	NULL
80	NULL
kD	NULL
1	NULL
2	NULL
3	NULL
4	NULL
S	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
Figure	NULL
3	NULL
.	NULL

IL-6	NULL
and	NULL
IL-6	NULL
receptor	NULL
expression	NULL
in	NULL
murine	NULL
fibroblasts	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Kinetics	NULL
of	NULL
IL6	NULL
secretion	NULL
in	NULL
B	NULL
line	NULL
cells	NULL
,	NULL
cultured	NULL
with	NULL
or	NULL
without	NULL
serum	NULL
.	NULL

Balb/c3T3	NULL
cultures	NULL
were	NULL
used	NULL
as	NULL
controls	NULL
for	NULL
ELISAs	NULL
.	NULL

Cells	NULL
were	NULL
grown	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
%	NULL
FCS	NULL
until	NULL
day	NULL
2	NULL
when	NULL
cells	NULL
were	NULL
60-80	NULL
%	NULL
confluent	NULL
.	NULL

The	NULL
concentration	NULL
of	NULL
secreted	NULL
IL-6	NULL
grown	NULL
in	NULL
10	NULL
%	NULL
serum	NULL
or	NULL
serum	NULL
free	NULL
conditions	NULL
was	NULL
calculated	NULL
using	NULL
an	NULL
IL-6	NULL
standard	NULL
#	NULL
:	NULL
$	NULL
__	NULL
curve	NULL
(	NULL
not	NULL
shown	NULL
here	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
the	NULL
IL-6	NULL
receptor	NULL
.	NULL

2.0	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
mRNA	NULL
obtained	NULL
from	NULL
B	NULL
line	NULL
cells	NULL
or	NULL
Balb/c	NULL
3T3	NULL
cells	NULL
were	NULL
hybridized	NULL
with	NULL
a	NULL
220-bp	NULL
fragment	NULL
of	NULL
mouse	NULL
IL-6R	NULL
cDNA	NULL
(	NULL
top	NULL
panel	NULL
)	NULL
and	NULL
an	NULL
actin	NULL
cDNA	NULL
control	NULL
(	NULL
bot-tom	NULL
panel	NULL
)	NULL
.	NULL

B	NULL
line	NULL
3T3	NULL
L-6	NULL
RP	NULL
Actin	NULL
-P	NULL
paracrine	NULL
stimulation	NULL
of	NULL
untransformed	NULL
fibroblasts	NULL
,	NULL
and	NULL
that	NULL
this	NULL
may	NULL
be	NULL
mediated	NULL
through	NULL
p130	NULL
phosphorylation	NULL
.	NULL

Phosphorylated	NULL
p130	NULL
identified	NULL
as	NULL
Jak2	NULL
in	NULL
the	NULL
Tax-transformed	NULL
transgenic	NULL
mouse	NULL
fibroblasts	NULL
and	NULL
as	NULL
Jak3	NULL
in	NULL
HTLV-1-transformed	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Recently	NULL
,	NULL
Jak	NULL
kinases	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
cytokine	NULL
signaling	NULL
pathway	NULL
for	NULL
IL6	NULL
(	NULL
12-14	NULL
)	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
IL-7	NULL
,	NULL
and	NULL
IL-9	NULL
(	NULL
15-19	NULL
)	NULL
.	NULL

The	NULL
similarity	NULL
in	NULL
size	NULL
between	NULL
Jak	NULL
family	NULL
members	NULL
and	NULL
our	NULL
p130	NULL
led	NULL
us	NULL
to	NULL
investigate	NULL
whether	NULL
our	NULL
tyrosine	NULL
phosphorylated	NULL
protein	NULL
belongs	NULL
to	NULL
this	NULL
family	NULL
.	NULL

Sequential	NULL
phosphortyrosine	NULL
immunoprecipita-tion	NULL
followed	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
Jak1	NULL
,	NULL
Jak2	NULL
,	NULL
and	NULL
Jak3	NULL
antibodies	NULL
were	NULL
performed	NULL
on	NULL
cellular	NULL
extracts	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak2	NULL
was	NULL
observed	NULL
in	NULL
tax	NULL
transformed	NULL
fibroblasts	NULL
(	NULL
B	NULL
line	NULL
)	NULL
,	NULL
but	NULL
not	NULL
in	NULL
Balb/c3T3	NULL
cells	NULL
(	NULL
fig	NULL
.	NULL

6A	NULL
,	NULL
left	NULL
panel	NULL
)	NULL
.	NULL

Both	NULL
cells	NULL
expressed	NULL
equal	NULL
amounts	NULL
of	NULL
total	NULL
Jak2	NULL
(	NULL
fig	NULL
.	NULL

6A	NULL
,	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

B	NULL
line	NULL
cells	NULL
showed	NULL
a	NULL
high	NULL
level	NULL
of	NULL
Jak2	NULL
protein	NULL
which	NULL
comigrates	NULL
with	NULL
phosphorylated	NULL
p130	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
B	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
,	NULL
and	NULL
undetectable	NULL
levels	NULL
of	NULL
Jak3	NULL
and	NULL
Jak1	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
B	NULL
,	NULL
lanes	NULL
I	NULL
and	NULL
3	NULL
)	NULL
.	NULL

Figure	NULL
4	NULL
.	NULL

Induction	NULL
of	NULL
p130	NULL
phosphorylation	NULL
in	NULL
Balb/c3T3	NULL
cells	NULL
.	NULL

Balb/c3T3	NULL
treated	NULL
with	NULL
B	NULL
supernatants	NULL
from	NULL
O	NULL
to	NULL
6	NULL
h	NULL
(	NULL
lanes	NULL
2/5	NULL
)	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
using	NULL
phosphotyrosine	NULL
antibody	NULL
.	NULL

B	NULL
line	NULL
cell	NULL
lysates	NULL
were	NULL
used	NULL
as	NULL
positive	NULL
controls	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
p130	NULL
phosphorylation	NULL
induction	NULL
by	NULL
neutralizing	NULL
antibodies	NULL
(	NULL
lanes	NULL
6-10	NULL
)	NULL
.	NULL

Equal	NULL
amount	NULL
of	NULL
lysates	NULL
(	NULL
15	NULL
ug	NULL
)	NULL
were	NULL
used	NULL
in	NULL
each	NULL
lane	NULL
.	NULL

The	NULL
location	NULL
of	NULL
tyrosine	NULL
phosphorylated	NULL
p130	NULL
is	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

Constitutive	NULL
Jak	NULL
Activation	NULL
by	NULL
HTLV-1	NULL
QTax	NULL
and	NULL
Virus	NULL
1551	NULL
80000	NULL
(	NULL
cpm	NULL
)	NULL
60000	NULL
-	NULL
3H	NULL
)	NULL
thymidine	NULL
incoporation	NULL
40000	NULL
20000	NULL
Figure	NULL
5	NULL
.	NULL

Proliferation	NULL
of	NULL
Balb/c3T3	NULL
cells	NULL
is	NULL
stimulated	NULL
by	NULL
B	NULL
line	NULL
cell	NULL
supernatants	NULL
or	NULL
mouse	NULL
recombinant	NULL
IL-6	NULL
.	NULL

[	NULL
°H	NULL
]	NULL
thymidine	NULL
incorporation	NULL
was	NULL
measured	NULL
in	NULL
Balb/c3T3	NULL
cells	NULL
grown	NULL
in	NULL
10	NULL
%	NULL
FCS	NULL
media	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
serum	NULL
free	NULL
media	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
mouse	NULL
recombinant	NULL
IL-6	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
mouse	NULL
recombinant	NULL
IL-6	NULL
with	NULL
neutralizing	NULL
IL-6	NULL
antibody	NULL
(	NULL
line	NULL
4	NULL
)	NULL
,	NULL
serum	NULL
free	NULL
B	NULL
line	NULL
cell	NULL
supernatants	NULL
without	NULL
IL-6	NULL
antibody	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
or	NULL
with	NULL
IL-6	NULL
antibody	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
after	NULL
overnight	NULL
incubation	NULL
with	NULL
[	NULL
°H	NULL
]	NULL
thymidine	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
are	NULL
the	NULL
means	NULL
of	NULL
three	NULL
determina-tion+SD	NULL
in	NULL
a	NULL
representative	NULL
experiment	NULL
.	NULL

Since	NULL
the	NULL
HTLV-1	NULL
transformed	NULL
human	NULL
lymphocyte	NULL
line	NULL
MT2	NULL
,	NULL
shows	NULL
phosphorylation	NULL
of	NULL
a	NULL
similar	NULL
p130	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
we	NULL
performed	NULL
identical	NULL
immunoprecipitate/	NULL
Western	NULL
analyses	NULL
of	NULL
lymphocytes	NULL
.	NULL

These	NULL
results	NULL
demonstrated	NULL
highly	NULL
phosphorylated	NULL
Jak3	NULL
in	NULL
HTLV-1	NULL
transformed	NULL
MT2	NULL
and	NULL
MT4	NULL
,	NULL
but	NULL
only	NULL
weak	NULL
phosphorylation	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
A	NULL
,	NULL
lanes	NULL
1-3	NULL
)	NULL
.	NULL

Jak2	NULL
was	NULL
also	NULL
weakly	NULL
phosphorylated	NULL
in	NULL
MT2	NULL
and	NULL
MT4	NULL
,	NULL
but	NULL
not	NULL
in	NULL
Jurkat	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
A	NULL
,	NULL
lanes	NULL
4-6	NULL
)	NULL
,	NULL
whereas	NULL
Jak1	NULL
expression	NULL
and	NULL
phosphorylation	NULL
were	NULL
undetectable	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
A	NULL
,	NULL
lanes	NULL
7-9	NULL
and	NULL
Fig	NULL
.	NULL

7	NULL
B	NULL
,	NULL
lane	NULL
o	NULL
o	NULL
E	NULL
m	NULL
£	NULL
m	NULL
I.—	NULL
m	NULL
®	NULL
ca	NULL
®	NULL
205	NULL
kD	NULL
-	NULL
R	NULL
«	NULL
wat	NULL
~~~	NULL
<	NULL
4-Jak2	NULL
4-	NULL
)	NULL
Jak2	NULL
116	NULL
kD	NULL
IP	NULL
+	NULL
western	NULL
ya	NULL
hunt	NULL
western	NULL
1552	NULL
Xu	NULL
et	NULL
al	NULL
.	NULL

205	NULL
kD	NULL
-	NULL
_-	NULL
w	NULL
@	NULL
eae	NULL
116	NULL
kD	NULL
so	NULL
kp	NULL
-	NULL
(	NULL
|	NULL
B	NULL
}	NULL
&	NULL
MB	NULL
a	NULL
l	NULL
1	NULL
)	NULL
.	NULL

In	NULL
MT2	NULL
cells	NULL
,	NULL
total	NULL
protein	NULL
expression	NULL
of	NULL
Jak3	NULL
was	NULL
also	NULL
increased	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
B	NULL
)	NULL
.	NULL

The	NULL
weak	NULL
phosphorylation	NULL
of	NULL
the	NULL
nondom-inant	NULL
Jak	NULL
2	NULL
in	NULL
MT2	NULL
and	NULL
MT4	NULL
cells	NULL
,	NULL
may	NULL
result	NULL
from	NULL
previously	NULL
described	NULL
aberrant	NULL
expression	NULL
of	NULL
IL-6	NULL
in	NULL
HTLV-1-infected	NULL
T	NULL
cells	NULL
(	NULL
9	NULL
)	NULL
,	NULL
or	NULL
may	NULL
reflect	NULL
true	NULL
interaction	NULL
between	NULL
Jak3	NULL
and	NULL
Jak2	NULL
kinases	NULL
in	NULL
this	NULL
system	NULL
.	NULL

Constitutive	NULL
phosphorylation	NULL
of	NULL
Jak3	NULL
was	NULL
also	NULL
seen	NULL
in	NULL
four	NULL
other	NULL
prototypic	NULL
HTLV-1	NULL
transformed	NULL
human	NULL
cell	NULL
lines	NULL
,	NULL
Hut102	NULL
,	NULL
C81-66	NULL
,	NULL
C91	NULL
,	NULL
and	NULL
C91-pl	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
C	NULL
)	NULL
,	NULL
and	NULL
therefore	NULL
appears	NULL
to	NULL
be	NULL
a	NULL
common	NULL
event	NULL
in	NULL
HTLV-1	NULL
transformation	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
HTLV-1	NULL
transformed	NULL
T-cells	NULL
,	NULL
immature	NULL
murine	NULL
thymocytes	NULL
do	NULL
not	NULL
express	NULL
Jak3	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
D	NULL
)	NULL
.	NULL

Discussion	NULL
We	NULL
have	NULL
shown	NULL
that	NULL
transformation	NULL
by	NULL
either	NULL
the	NULL
tax	NULL
gene	NULL
or	NULL
HTLV-1	NULL
virus	NULL
is	NULL
associated	NULL
with	NULL
constitutive	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak	NULL
kinase	NULL
family	NULL
members	NULL
.	NULL

The	NULL
dominant	NULL
species	NULL
is	NULL
Jak2	NULL
in	NULL
tax	NULL
transformed	NULL
fibroblasts	NULL
and	NULL
Jak3	NULL
in	NULL
HTLV-1-transformed	NULL
human	NULL
lymphocytes	NULL
.	NULL

Phosphorylation	NULL
of	NULL
the	NULL
IL-6	NULL
gp130	NULL
receptor	NULL
may	NULL
also	NULL
contribute	NULL
to	NULL
the	NULL
signal	NULL
seen	NULL
on	NULL
crude	NULL
phosphotyrosine	NULL
blots	NULL
.	NULL

These	NULL
results	NULL
provide	NULL
the	NULL
first	NULL
evidence	NULL
that	NULL
specific	NULL
Jak	NULL
kinase	NULL
activation	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
HTLV-1	NULL
or	NULL
tax	NULL
transformation	NULL
.	NULL

Jak/Tyk	NULL
family	NULL
members	NULL
have	NULL
been	NULL
previously	NULL
shown	NULL
to	NULL
propagate	NULL
growth	NULL
factor	NULL
and	NULL
cytokine	NULL
mediated	NULL
effects	NULL
on	NULL
mitogenesis	NULL
and	NULL
differentiation	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
.	NULL

Particular	NULL
cytokines	NULL
appear	NULL
to	NULL
induce	NULL
distinct	NULL
patterns	NULL
of	NULL
Jak/Tyk	NULL
phosphorylation	NULL
in	NULL
different	NULL
cell	NULL
lines	NULL
.	NULL

For	NULL
example	NULL
,	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak	NULL
!	NULL

and	NULL
Jak2	NULL
but	NULL
not	NULL
Tyk2	NULL
was	NULL
always	NULL
observed	NULL
after	NULL
stimulation	NULL
with	NULL
CNTF	NULL
,	NULL
IL-6	NULL
,	NULL
LIF	NULL
,	NULL
and	NULL
OSM	NULL
(	NULL
12	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
stimulation	NULL
of	NULL
INF-a	NULL
usually	NULL
induces	NULL
phosphorylation	NULL
of	NULL
Tyk2	NULL
and	NULL
Jak1	NULL
but	NULL
not	NULL
Jak2	NULL
(	NULL
27	NULL
,	NULL
28	NULL
)	NULL
.	NULL

Jak3	NULL
activation	NULL
appears	NULL
restricted	NULL
to	NULL
mature	NULL
lymphocytes	NULL
and	NULL
is	NULL
linked	NULL
to	NULL
activation	NULL
by	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
IL-7	NULL
,	NULL
and	NULL
IL-9	NULL
(	NULL
16	NULL
,	NULL
29	NULL
)	NULL
.	NULL

In	NULL
tax-transformed	NULL
mouse	NULL
fibroblasts	NULL
,	NULL
phosphorylation	NULL
of	NULL
Jak2	NULL
but	NULL
not	NULL
other	NULL
family	NULL
members	NULL
appeared	NULL
dominant	NULL
,	NULL
whereas	NULL
both	NULL
up	NULL
modulation	NULL
and	NULL
phosphorylation	NULL
of	NULL
Jak3	NULL
was	NULL
dominant	NULL
in	NULL
HTLV-1	NULL
transformed	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
tax	NULL
transformed	NULL
mouse	NULL
fibroblasts	NULL
,	NULL
activation	NULL
of	NULL
Jak2	NULL
occurs	NULL
in	NULL
response	NULL
to	NULL
IL-6	NULL
.	NULL

IL-6	NULL
expression	NULL
has	NULL
been	NULL
demonstrated	NULL
to	NULL
be	NULL
highly	NULL
up-modulated	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
at	NULL
least	NULL
partially	NULL
as	NULL
a	NULL
consequence	NULL
of	NULL
NF-KB	NULL
activation	NULL
(	NULL
11	NULL
,	NULL
24	NULL
,	NULL
30	NULL
)	NULL
by	NULL
tax	NULL
.	NULL

Results	NULL
from	NULL
ELISA	NULL
reveal	NULL
high	NULL
levels	NULL
of	NULL
IL-6	NULL
secreted	NULL
into	NULL
the	NULL
media	NULL
even	NULL
when	NULL
these	NULL
cells	NULL
are	NULL
serum	NULL
starved	NULL
.	NULL

Furthermore	NULL
,	NULL
IL-6	NULL
receptor	NULL
mRNA	NULL
was	NULL
also	NULL
detected	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
interaction	NULL
of	NULL
IL-	NULL
Figure	NULL
6	NULL
.	NULL

Identification	NULL
of	NULL
phosphorylated	NULL
Jak2	NULL
in	NULL
Tax	NULL
transformed	NULL
mouse	NULL
fibroblasts	NULL
.	NULL

(	NULL
A	NULL
)	NULL
50	NULL
ug	NULL
of	NULL
B	NULL
line	NULL
or	NULL
Balb/c3T3	NULL
cell	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
a	NULL
phosphotyrosine	NULL
specific	NULL
antibody	NULL
followed	NULL
by	NULL
immu-	NULL
#	NULL
s	NULL
:	NULL
5	NULL
noblot	NULL
detection	NULL
with	NULL
a	NULL
Jak2	NULL
specific	NULL
can	NULL
wig	NULL
_._	NULL
antibody	NULL
(	NULL
Zeft	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
right	NULL
panel	NULL
ﬁ	NULL
&	NULL
__	NULL
shows	NULL
for	NULL
comparison	NULL
,	NULL
total	NULL
Jak2	NULL
levels	NULL
in	NULL
15	NULL
ug	NULL
of	NULL
B	NULL
line	NULL
or	NULL
Balb/c3T3	NULL
cell	NULL
lysates	NULL
.	NULL

Jak2	NULL
protein	NULL
is	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Western	NULL
blot	NULL
comparison	NULL
of	NULL
Jak	NULL
proteins	NULL
in	NULL
the	NULL
B	NULL
line	NULL
cells	NULL
.	NULL

15	NULL
ug	NULL
of	NULL
cellular	NULL
lysate	NULL
were	NULL
used	NULL
per	NULL
lane	NULL
.	NULL

Antibodies	NULL
are	NULL
indicated	NULL
.	NULL

B	NULL
line	NULL
F	NULL
~	NULL
~	NULL
o	NULL
s	NULL
}	NULL
Jak1	NULL
Jak2	NULL
Jak3	NULL
pT	NULL
w	NULL
1	NULL
2	NULL
3	NULL
4	NULL
a-Jak3	NULL
a	NULL
-Jak2	NULL
a-Jak1	NULL
A	NULL
-	NULL
E	NULL
1	NULL
O-	NULL
E	NULL
1	NULL
F	NULL
_	NULL
J	NULL
~	NULL
#	NULL
#	NULL
a-	NULL
§	NULL
g	NULL
8	NULL
3	NULL
§	NULL
§	NULL
1	NULL
§	NULL
§	NULL
1	NULL
&	NULL
205	NULL
kD	NULL
_	NULL
,	NULL
am	NULL
aoa	NULL
.	NULL

«	NULL
»	NULL
«	NULL
116	NULL
kD	NULL
_	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
IP	NULL
+	NULL
Western	NULL
D	NULL
C	NULL
o	NULL
205	NULL
kD	NULL
N	NULL
_	NULL
A	NULL
-	NULL
O	NULL
Ch	NULL
@	NULL
a	NULL
4	NULL
9	NULL
A	NULL
a	NULL
go	NULL
116	NULL
kD	NULL
a	NULL
a	NULL
®	NULL
a	NULL
=	NULL
2	NULL
aA	NULL
8	NULL
6	NULL
0	NULL
80	NULL
kD	NULL
49	NULL
kD	NULL
Jak3	NULL
-	NULL
>	NULL
IP	NULL
+	NULL
Western	NULL
Figure	NULL
7	NULL
.	NULL

Identification	NULL
of	NULL
Jak	NULL
species	NULL
in	NULL
HTLV-1	NULL
transformed	NULL
human	NULL
lymp	NULL
!	NULL

B	NULL
MT2	NULL
OCO	NULL
J	NULL
Jak1	NULL
Jak2	NULL
Jak3	NULL
pT	NULL
205	NULL
kD	NULL
-	NULL
m	NULL
o	NULL
>	NULL
Wh	NULL
U	NULL
116	NULL
kD	NULL
-	NULL
own	NULL
|	NULL
Wit	NULL
--	NULL
thymocytes	NULL
thymocytes	NULL
tax	NULL
MT	NULL
2	NULL
tax+	NULL
4-	NULL
Jak3	NULL
ey	NULL
1	NULL
2	NULL
3	NULL
hocytes	NULL
and	NULL
murine	NULL
tax	NULL
expressing	NULL
thymocytes	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Phosphorylation	NULL
of	NULL
Jak1-3	NULL
in	NULL
MT2	NULL
,	NULL
MT4	NULL
and	NULL
Jurkat	NULL
cells	NULL
.	NULL

50	NULL
ug	NULL
of	NULL
cell	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
phosphotyrosine	NULL
antibody	NULL
followed	NULL
by	NULL
Western	NULL
blotting	NULL
analysis	NULL
with	NULL
Jak3	NULL
(	NULL
lanes	NULL
1-3	NULL
)	NULL
,	NULL
Jak2	NULL
(	NULL
lanes	NULL
4-6	NULL
)	NULL
and	NULL
Jak1	NULL
(	NULL
lanes	NULL
7-9	NULL
)	NULL
antibodies	NULL
.	NULL

Phosphorylated	NULL
Jak	NULL
kinases	NULL
were	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Western	NULL
blot	NULL
comparisons	NULL
of	NULL
Jak1-3	NULL
total	NULL
protein	NULL
levels	NULL
in	NULL
MT2	NULL
(	NULL
lanes	NULL
1-4	NULL
)	NULL
Jak1	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
Jak2	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
Jak3	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
or	NULL
phosphotyrosine	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
antibodies	NULL
.	NULL

15	NULL
ug	NULL
of	NULL
MT2	NULL
or	NULL
B	NULL
line	NULL
cell	NULL
lysates	NULL
were	NULL
used	NULL
in	NULL
each	NULL
lane	NULL
.	NULL

The	NULL
location	NULL
of	NULL
corresponding	NULL
Jak	NULL
kinases	NULL
is	NULL
indicated	NULL
by	NULL
a	NULL
long	NULL
arrow	NULL
.	NULL

The	NULL
shorter	NULL
arrow	NULL
indicates	NULL
degraded	NULL
Jak2	NULL
.	NULL

(	NULL
C	NULL
Phosphorylation	NULL
of	NULL
Jak3	NULL
in	NULL
four	NULL
more	NULL
HTLV-1	NULL
transformed	NULL
human	NULL
T-cells	NULL
(	NULL
Hut102	NULL
,	NULL
lane	NULL
3	NULL
;	NULL
C91-	NULL
pl	NULL
,	NULL
lane	NULL
4	NULL
;	NULL
C91-	NULL
,	NULL
lane	NULL
5	NULL
;	NULL
and	NULL
C81-66	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

This	NULL
time	NULL
MT2	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
and	NULL
Jurkat	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
cell	NULL
lysates	NULL
were	NULL
used	NULL
as	NULL
positive	NULL
and	NULL
negative	NULL
controls	NULL
.	NULL

The	NULL
phosphorylated	NULL
Jak3	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Expression	NULL
of	NULL
Jak3	NULL
in	NULL
thymocytes	NULL
from	NULL
Thy-tax	NULL
transgenic	NULL
mice	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
normal	NULL
mice	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
or	NULL
MT2	NULL
cell	NULL
lysates	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

Direct	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
Jak3	NULL
specific	NULL
antibodies	NULL
.	NULL

6	NULL
with	NULL
its	NULL
cognate	NULL
receptor	NULL
in	NULL
tax	NULL
transformed	NULL
mouse	NULL
fibroblasts	NULL
may	NULL
further	NULL
stimulate	NULL
cells	NULL
by	NULL
the	NULL
Jak2	NULL
signaling	NULL
pathway	NULL
.	NULL

In	NULL
vitro	NULL
stimulation	NULL
by	NULL
supernatants	NULL
from	NULL
B	NULL
line	NULL
cell	NULL
cultures	NULL
induced	NULL
specific	NULL
phosphorylation	NULL
of	NULL
Jak2	NULL
in	NULL
Balb/c	NULL
3T3	NULL
cells	NULL
,	NULL
and	NULL
simultaneous	NULL
proliferation	NULL
.	NULL

Both	NULL
phosphorylation	NULL
and	NULL
proliferation	NULL
were	NULL
specifically	NULL
inhibited	NULL
by	NULL
IL-6	NULL
neutralizing	NULL
antibody	NULL
suggesting	NULL
a	NULL
direct	NULL
correlation	NULL
between	NULL
activation	NULL
of	NULL
the	NULL
autocrine	NULL
loop	NULL
and	NULL
cell	NULL
proliferation	NULL
.	NULL

Constitutive	NULL
activation	NULL
of	NULL
Jak2	NULL
by	NULL
IL-6/IL-6R	NULL
may	NULL
not	NULL
only	NULL
result	NULL
in	NULL
autocrine	NULL
cell	NULL
proliferation	NULL
but	NULL
may	NULL
also	NULL
cause	NULL
paracrine	NULL
effects	NULL
on	NULL
other	NULL
cells	NULL
.	NULL

For	NULL
example	NULL
,	NULL
hyperplasia	NULL
of	NULL
bone	NULL
stroma	NULL
,	NULL
and	NULL
multiple	NULL
hematopoetic	NULL
bone	NULL
marrow	NULL
precursors	NULL
,	NULL
as	NULL
well	NULL
as	NULL
muscle	NULL
wasting	NULL
are	NULL
commonly	NULL
seen	NULL
in	NULL
transgenic	NULL
mice	NULL
bearing	NULL
IL-6	NULL
secreting	NULL
fibrosarcomas	NULL
.	NULL

IL-6	NULL
,	NULL
IL-2	NULL
,	NULL
and	NULL
IL-2Ra	NULL
are	NULL
well	NULL
known	NULL
to	NULL
be	NULL
up-modulated	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
tax	NULL
or	NULL
HTLV-1	NULL
transformed	NULL
cells	NULL
(	NULL
5	NULL
,	NULL
6	NULL
,	NULL
11	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
tax	NULL
may	NULL
release	NULL
NF-	NULL
«	NULL
B	NULL
from	NULL
an	NULL
inactive	NULL
complex	NULL
by	NULL
physically	NULL
interacting	NULL
with	NULL
I-	NULL
«	NULL
B	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IL6	NULL
does	NULL
not	NULL
induce	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
normal	NULL
fibroblasts	NULL
or	NULL
in	NULL
tax	NULL
transformed	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
nor	NULL
has	NULL
it	NULL
been	NULL
reported	NULL
by	NULL
others	NULL
to	NULL
our	NULL
knowledge	NULL
.	NULL

Thus	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
not	NULL
capable	NULL
of	NULL
activating	NULL
itself	NULL
through	NULL
this	NULL
loop	NULL
.	NULL

In	NULL
our	NULL
studies	NULL
,	NULL
the	NULL
role	NULL
of	NULL
tax	NULL
appears	NULL
to	NULL
be	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
which	NULL
in	NULL
turn	NULL
induces	NULL
IL6	NULL
.	NULL

High	NULL
level	NULL
Constitutive	NULL
Jak	NULL
Activation	NULL
by	NULL
HTLV-1	NULL
QTax	NULL
and	NULL
Virus	NULL
1553	NULL
IL-6	NULL
expression	NULL
then	NULL
leads	NULL
to	NULL
Jak2	NULL
phosphorylation	NULL
.	NULL

Factors	NULL
downstream	NULL
of	NULL
Jak	NULL
kinases	NULL
such	NULL
as	NULL
Stat	NULL
and	NULL
MAP	NULL
kinase	NULL
family	NULL
members	NULL
remain	NULL
to	NULL
be	NULL
elucidated	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
other	NULL
IL-6	NULL
independent	NULL
mechanisms	NULL
of	NULL
tax	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
transformation	NULL
.	NULL

For	NULL
example	NULL
,	NULL
Jak2	NULL
kinase	NULL
may	NULL
also	NULL
be	NULL
partially	NULL
activated	NULL
by	NULL
other	NULL
overexpressed	NULL
cytokines	NULL
.	NULL

Their	NULL
resulting	NULL
signaling	NULL
cascades	NULL
might	NULL
cause	NULL
further	NULL
disregulation	NULL
of	NULL
cellular	NULL
genes	NULL
(	NULL
37	NULL
,	NULL
38	NULL
)	NULL
involved	NULL
in	NULL
tumorigenesis	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
Jak3	NULL
has	NULL
been	NULL
associated	NULL
with	NULL
T	NULL
cell	NULL
activation	NULL
by	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
IL-7	NULL
,	NULL
and	NULL
IL-9	NULL
through	NULL
the	NULL
IL-2R	NULL
(	NULL
15-19	NULL
)	NULL
.	NULL

The	NULL
IL-2	NULL
receptor	NULL
consist	NULL
of	NULL
an	NULL
«	NULL
-chain	NULL
,	NULL
3-chain	NULL
,	NULL
and	NULL
y-chain	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
«	NULL
-chain	NULL
is	NULL
highly	NULL
upregu-lated	NULL
by	NULL
tax/rex	NULL
gene	NULL
products	NULL
in	NULL
HTLV-1	NULL
transformed	NULL
human	NULL
T	NULL
lymphocytes	NULL
(	NULL
6	NULL
,	NULL
33	NULL
)	NULL
.	NULL

However	NULL
,	NULL
upregulation	NULL
of	NULL
the	NULL
y	NULL
,	NULL
chain	NULL
has	NULL
also	NULL
been	NULL
linked	NULL
to	NULL
HTLV-1	NULL
infection	NULL
and	NULL
tax	NULL
activation	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Although	NULL
induction	NULL
of	NULL
IL-2	NULL
and	NULL
IL-2Ra	NULL
are	NULL
important	NULL
events	NULL
in	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
,	NULL
it	NULL
is	NULL
the	NULL
3-	NULL
and	NULL
y	NULL
,	NULL
-chain	NULL
that	NULL
mediate	NULL
signal	NULL
transduction	NULL
(	NULL
15-19	NULL
)	NULL
.	NULL

The	NULL
mem-brane-proximal	NULL
,	NULL
serine-rich	NULL
domains	NULL
of	NULL
these	NULL
proteins	NULL
interact	NULL
with	NULL
Jak3	NULL
kinase	NULL
and	NULL
are	NULL
required	NULL
for	NULL
cytokine	NULL
mediated	NULL
mitogenesis	NULL
(	NULL
16	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
IL-2	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
IL-2Ra	NULL
,	NULL
y	NULL
,	NULL
HTLV-1	NULL
infected	NULL
T	NULL
cells	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
express	NULL
a	NULL
multitude	NULL
of	NULL
other	NULL
cytokines	NULL
including	NULL
IL-3	NULL
,	NULL
IL-4	NULL
,	NULL
IL-5	NULL
,	NULL
TNF-	NULL
$	NULL
,	NULL
and	NULL
GM-CSF	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Among	NULL
them	NULL
,	NULL
IL-4	NULL
was	NULL
recently	NULL
reported	NULL
to	NULL
activate	NULL
T-cell	NULL
proliferation	NULL
by	NULL
activation	NULL
of	NULL
Jak3	NULL
through	NULL
the	NULL
IL-2y	NULL
chain	NULL
(	NULL
17-19	NULL
)	NULL
.	NULL

IL-15	NULL
may	NULL
activate	NULL
similarly	NULL
(	NULL
41	NULL
,	NULL
42	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
HTLV-1	NULL
-transformed	NULL
human	NULL
lymphocytes	NULL
,	NULL
constitutive	NULL
activation	NULL
of	NULL
Jak3	NULL
is	NULL
most	NULL
likely	NULL
a	NULL
result	NULL
of	NULL
disregulation	NULL
of	NULL
one	NULL
or	NULL
more	NULL
of	NULL
these	NULL
cytokine	NULL
genes	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
IL-2	NULL
receptor	NULL
subunit	NULL
genes	NULL
.	NULL

Furthermore	NULL
,	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
infected	NULL
with	NULL
whole	NULL
virus	NULL
,	NULL
virus	NULL
encoded	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
other	NULL
than	NULL
tax	NULL
may	NULL
also	NULL
contribute	NULL
to	NULL
activation	NULL
of	NULL
Jak3	NULL
(	NULL
39	NULL
,	NULL
40	NULL
)	NULL
.	NULL

Future	NULL
identification	NULL
of	NULL
additional	NULL
downstream	NULL
cytokine	NULL
and	NULL
other	NULL
targets	NULL
of	NULL
tax	NULL
in	NULL
additional	NULL
leukemic	NULL
cell	NULL
lines	NULL
and	NULL
fresh	NULL
patient	NULL
isolates	NULL
will	NULL
be	NULL
critical	NULL
for	NULL
understanding	NULL
pathogenesis	NULL
and	NULL
therapeutic	NULL
approaches	NULL
to	NULL
this	NULL
unusual	NULL
leukemia	NULL
.	NULL

Acknowledgments	NULL
We	NULL
would	NULL
like	NULL
to	NULL
thank	NULL
Drs	NULL
.	NULL

I.	NULL
Verma	NULL
,	NULL
Y.	NULL
Q.	NULL
Chen	NULL
,	NULL
I.	NULL
Kitajima	NULL
,	NULL
D.	NULL
Brown	NULL
,	NULL
and	NULL
K.	NULL
McGuire	NULL
for	NULL
reagents	NULL
and	NULL
advice	NULL
.	NULL

This	NULL
study	NULL
was	NULL
supported	NULL
by	NULL
NIH	NULL
grant	NULL
NS-12428	NULL
and	NULL
CA-5023	NULL
to	NULL
M.	NULL
I.	NULL
Nerenberg	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Poistz	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
F.	NULL
W.	NULL
Ruscetti	NULL
,	NULL
M.	NULL
S.	NULL
Reitz	NULL
,	NULL
V.	NULL
S.	NULL
Kalyanaraman	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Gallo	NULL
.	NULL

1981	NULL
.	NULL

Isolation	NULL
of	NULL
a	NULL
new	NULL
type	NULL
C	NULL
retrovirus	NULL
(	NULL
HTLV-1	NULL
)	NULL
in	NULL
primary	NULL
uncultured	NULL
cells	NULL
of	NULL
a	NULL
patient	NULL
with	NULL
Sezary	NULL
T	NULL
cell	NULL
leukemia	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

249:268-271	NULL
.	NULL

2	NULL
.	NULL

Miyoshi	NULL
,	NULL
I.	NULL
,	NULL
I.	NULL
Kubonishi	NULL
,	NULL
S.	NULL
Yoshimoto	NULL
,	NULL
T.	NULL
Akagi	NULL
,	NULL
Y.	NULL
Ohtsuki	NULL
,	NULL
Y.	NULL
Shiraishi	NULL
,	NULL
K.	NULL
Nagata	NULL
,	NULL
and	NULL
Y.	NULL
Hinuma	NULL
.	NULL

1981	NULL
.	NULL

Type	NULL
C	NULL
virus	NULL
particles	NULL
in	NULL
a	NULL
cord	NULL
T-cell	NULL
line	NULL
derived	NULL
by	NULL
co-cultivating	NULL
normal	NULL
human	NULL
cord	NULL
leukocytes	NULL
and	NULL
human	NULL
leukaemic	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

294:770-771	NULL
.	NULL

3	NULL
.	NULL

Gessain	NULL
,	NULL
A.	NULL
,	NULL
F.	NULL
Barin	NULL
,	NULL
J.	NULL
C.	NULL
Vermnant	NULL
,	NULL
O.	NULL
Gout	NULL
,	NULL
L.	NULL
Maurs	NULL
,	NULL
A.	NULL
Calender	NULL
,	NULL
and	NULL
G.	NULL
de	NULL
The	NULL
.	NULL

1985	NULL
.	NULL

Antibodies	NULL
to	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type-I	NULL
in	NULL
patients	NULL
with	NULL
tropical	NULL
spastic	NULL
paraparesis	NULL
.	NULL

Lancet	NULL
.	NULL

2:407-410	NULL
.	NULL

4	NULL
.	NULL

Osame	NULL
,	NULL
M.	NULL
,	NULL
K.	NULL
Usuku	NULL
,	NULL
S.	NULL
Izumo	NULL
,	NULL
N.	NULL
H.	NULL
Amitani	NULL
,	NULL
A.	NULL
Igata	NULL
,	NULL
M.	NULL
Matsumoto	NULL
,	NULL
and	NULL
M.	NULL
Tara	NULL
.	NULL

1986	NULL
.	NULL

HTLV-1	NULL
associated	NULL
myelopathy	NULL
,	NULL
a	NULL
new	NULL
clinical	NULL
entity	NULL
.	NULL

Lancet	NULL
.	NULL

1	NULL
:	NULL
1031-1032	NULL
.	NULL

5	NULL
.	NULL

Gitlin	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
J.	NULL
Dittmer	NULL
,	NULL
R.	NULL
L.	NULL
Reid	NULL
,	NULL
and	NULL
J.	NULL
N.	NULL
Brady	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
molecular	NULL
biology	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
viruses	NULL
.	NULL

p.	NULL
159-192	NULL
.	NULL

In	NULL
B.	NULL
Cullen	NULL
,	NULL
editor	NULL
.	NULL

Frontier	NULL
in	NULL
Molecular	NULL
Biology	NULL
.	NULL

Oxford	NULL
University	NULL
Press	NULL
.	NULL

Oxford	NULL
,	NULL
England	NULL
.	NULL

6	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
J.	NULL
W.	NULL
Lowenthal	NULL
,	NULL
Y.	NULL
Wano	NULL
,	NULL
B.	NULL
R.	NULL
Franza	NULL
,	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1988	NULL
.	NULL

HTLV-1	NULL
Tax	NULL
induces	NULL
cellular	NULL
proteins	NULL
that	NULL
activate	NULL
the	NULL
«	NULL
B	NULL
element	NULL
in	NULL
the	NULL
IL-2	NULL
receptor	NULL
gene	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

241:1652-1655	NULL
.	NULL

7	NULL
.	NULL

Maruyama	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Shibuya	NULL
,	NULL
H.	NULL
Harada	NULL
,	NULL
M.	NULL
Hatakeyama	NULL
,	NULL
M.	NULL
Seiki	NULL
,	NULL
T.	NULL
Fujita	NULL
,	NULL
J.	NULL
Inoue	NULL
,	NULL
M.	NULL
Yoshida	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1987	NULL
.	NULL

Evidence	NULL
for	NULL
aberrant	NULL
activation	NULL
1554	NULL
Xu	NULL
et	NULL
al	NULL
.	NULL

of	NULL
the	NULL
interleukin-2	NULL
autocrine	NULL
loop	NULL
by	NULL
HTLV-1-encoded	NULL
p40x	NULL
and	NULL
T3/Ti	NULL
complex	NULL
triggering	NULL
.	NULL

Cell	NULL
.	NULL

48:343-350	NULL
.	NULL

8	NULL
.	NULL

Noma	NULL
,	NULL
T.	NULL
,	NULL
H.	NULL
Nakakubo	NULL
,	NULL
M.	NULL
Sugita	NULL
,	NULL
S.	NULL
Kamagai	NULL
,	NULL
M.	NULL
Maeda	NULL
,	NULL
A.	NULL
Shimizu	NULL
,	NULL
and	NULL
T.	NULL
Honjo	NULL
.	NULL

1989	NULL
.	NULL

Expression	NULL
of	NULL
different	NULL
combinations	NULL
of	NULL
interleukins	NULL
by	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
cell	NULL
lines	NULL
that	NULL
are	NULL
clonally	NULL
related	NULL
.	NULL

J	NULL
.	NULL

£xp	NULL
.	NULL

Med	NULL
.	NULL

169:1853	NULL
.	NULL

9	NULL
.	NULL

Villiger	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
M.	NULL
T.	NULL
Cronin	NULL
,	NULL
T.	NULL
Amenomori	NULL
,	NULL
W.	NULL
Wachsman	NULL
,	NULL
and	NULL
M.	NULL
Lotz	NULL
.	NULL

1991	NULL
.	NULL

IL-6	NULL
expression	NULL
by	NULL
human	NULL
T	NULL
lymphocytes	NULL
:	NULL
expression	NULL
in	NULL
HTLV-1-infected	NULL
but	NULL
not	NULL
normal	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

146:550-559	NULL
.	NULL

10	NULL
.	NULL

Nerenberg	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
H.	NULL
Hinrichs	NULL
,	NULL
R.	NULL
K.	NULL
Reynolds	NULL
,	NULL
G.	NULL
Khoury	NULL
,	NULL
and	NULL
G.	NULL
Jay	NULL
.	NULL

1987	NULL
.	NULL

The	NULL
tat	NULL
gene	NULL
of	NULL
human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type-1	NULL
induces	NULL
mesenchy-mal	NULL
tumors	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

237:1324-1329	NULL
.	NULL

11	NULL
.	NULL

Kitajima	NULL
,	NULL
L.	NULL
,	NULL
T.	NULL
Shinohara	NULL
,	NULL
J.	NULL
Bilokovics	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

Brown	NULL
,	NULL
X.	NULL
Xu	NULL
,	NULL
and	NULL
M.	NULL
I.	NULL
Nerenberg	NULL
.	NULL

1992	NULL
.	NULL

Ablation	NULL
of	NULL
transplated	NULL
HTLV-1	NULL
tax-transformed	NULL
tumors	NULL
in	NULL
mice	NULL
by	NULL
antisense	NULL
inhibition	NULL
of	NULL
NF-kB	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

258:1792-1795	NULL
.	NULL

12	NULL
.	NULL

Stahl	NULL
.	NULL

N.	NULL
,	NULL
T.	NULL
G.	NULL
Boulton	NULL
,	NULL
T.	NULL
Farruggella	NULL
,	NULL
N.	NULL
Y.	NULL
Ip	NULL
,	NULL
S.	NULL
Davis	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Witthuhn	NULL
,	NULL
F.	NULL
W.	NULL
Quelle	NULL
,	NULL
O.	NULL
Silvennoinen	NULL
,	NULL
G.	NULL
Barbieri	NULL
,	NULL
S.	NULL
Pellegrini	NULL
,	NULL
J.	NULL
N.	NULL
Thile	NULL
,	NULL
and	NULL
C.	NULL
D.	NULL
Yancopoulos	NULL
.	NULL

1994	NULL
.	NULL

Association	NULL
and	NULL
activation	NULL
of	NULL
Jak-Tyk	NULL
kinases	NULL
by	NULL
CNTF-OSM-IL-6	NULL
#	NULL
receptor	NULL
components	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

263:92-95	NULL
.	NULL

13	NULL
.	NULL

Lutticken	NULL
,	NULL
C.	NULL
,	NULL
U.	NULL
M.	NULL
Wegenka	NULL
,	NULL
J.	NULL
Yuan	NULL
,	NULL
J.	NULL
Buschmann	NULL
,	NULL
C.	NULL
Schindler	NULL
,	NULL
A.	NULL
Ziemiecki	NULL
,	NULL
A.	NULL
G.	NULL
Harper	NULL
,	NULL
A.	NULL
F.	NULL
Wils	NULL
,	NULL
K.	NULL
Yasukawa	NULL
,	NULL
T.	NULL
Taga	NULL
,	NULL
T.	NULL
Kishimoto	NULL
,	NULL
G.	NULL
Barbieri	NULL
,	NULL
S.	NULL
Pellegrini	NULL
,	NULL
M.	NULL
Sendtner	NULL
,	NULL
P.	NULL
C.	NULL
Heinrich	NULL
,	NULL
and	NULL
F.	NULL
Horn	NULL
.	NULL

1994	NULL
.	NULL

Association	NULL
of	NULL
transcription	NULL
factor	NULL
APRF	NULL
and	NULL
protein	NULL
kinase	NULL
Jak1	NULL
with	NULL
the	NULL
interleukin-6	NULL
signal	NULL
transducer	NULL
gp	NULL
130	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

263:89-92	NULL
.	NULL

14	NULL
.	NULL

Quelle	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
N.	NULL
Sato	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Witthuhn	NULL
,	NULL
R.	NULL
C.	NULL
Inhorn	NULL
,	NULL
M.	NULL
Eder	NULL
,	NULL
A.	NULL
Miyajima	NULL
,	NULL
J.	NULL
D.	NULL
Griffin	NULL
,	NULL
and	NULL
J.	NULL
N.	NULL
Thie	NULL
.	NULL

1994	NULL
.	NULL

Jak2	NULL
associates	NULL
with	NULL
the	NULL
Bc	NULL
chain	NULL
of	NULL
the	NULL
receptor	NULL
for	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
,	NULL
and	NULL
its	NULL
activation	NULL
requires	NULL
the	NULL
membrane-proximal	NULL
region	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:4335-4341	NULL
.	NULL

15	NULL
.	NULL

Kawamura	NULL
,	NULL
M.	NULL
,	NULL
D.	NULL
W.	NULL
McVicar	NULL
,	NULL
J.	NULL
a.	NULL
Johnston	NULL
,	NULL
T.	NULL
B.	NULL
Blake	NULL
,	NULL
Y.	NULL
Q.	NULL
Chen	NULL
,	NULL
B.	NULL
K.	NULL
Lai	NULL
,	NULL
A.	NULL
R.	NULL
Lloyd	NULL
,	NULL
D.	NULL
J.	NULL
Kelvin	NULL
,	NULL
J.	NULL
E.	NULL
Staples	NULL
,	NULL
J.	NULL
R.	NULL
Ortaldo	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
O'Shea	NULL
.	NULL

1994	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
L-JAK	NULL
,	NULL
a	NULL
Janus	NULL
family	NULL
protein-tyrosine	NULL
kinase	NULL
expressed	NULL
in	NULL
natural	NULL
killer	NULL
cells	NULL
and	NULL
activated	NULL
leukocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

91:6374-6378	NULL
.	NULL

16	NULL
.	NULL

Witthuhn	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
O.	NULL
Silvennoinen	NULL
,	NULL
O.	NULL
Miura	NULL
,	NULL
K.	NULL
S.	NULL
Lai	NULL
,	NULL
C.	NULL
Cwik	NULL
,	NULL
E.	NULL
T.	NULL
Liu	NULL
and	NULL
J.	NULL
N.	NULL
Ihle	NULL
.	NULL

1994	NULL
.	NULL

Involvement	NULL
of	NULL
the	NULL
Jak-3	NULL
Janus	NULL
kinase	NULL
in	NULL
signaling	NULL
by	NULL
interleukins	NULL
2	NULL
and	NULL
4	NULL
in	NULL
lymphoid	NULL
and	NULL
myeloid	NULL
cells	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

370:153-157	NULL
.	NULL

17	NULL
.	NULL

Boussiotis	NULL
,	NULL
V.	NULL
A.	NULL
,	NULL
D.	NULL
L.	NULL
Barber	NULL
,	NULL
T.	NULL
Nakarai	NULL
,	NULL
G.	NULL
J.	NULL
Freeman	NULL
,	NULL
J.	NULL
G.	NULL
Gribben	NULL
,	NULL
G.	NULL
M.	NULL
Bernstein	NULL
,	NULL
A.	NULL
D.	NULL
D'Andrea	NULL
,	NULL
J.	NULL
Ritz	NULL
,	NULL
L.	NULL
M.	NULL
Nadler	NULL
.	NULL

1994	NULL
.	NULL

Prevention	NULL
of	NULL
T	NULL
cell	NULL
anergy	NULL
by	NULL
signaling	NULL
through	NULL
the	NULL
yc	NULL
chain	NULL
of	NULL
the	NULL
IL-2	NULL
receptor	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

266:1039-1042	NULL
.	NULL

18	NULL
.	NULL

Russell	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Johnston	NULL
,	NULL
M.	NULL
Noguchi	NULL
,	NULL
M.	NULL
Kawamura	NULL
,	NULL
C.	NULL
M.	NULL
Bacon	NULL
,	NULL
M.	NULL
Friedmann	NULL
,	NULL
M.	NULL
Berg	NULL
,	NULL
D.	NULL
W.	NULL
McVicar	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Witthuhn	NULL
,	NULL
O.	NULL
Silvennoinen	NULL
,	NULL
A.	NULL
S.	NULL
Goldman	NULL
,	NULL
F.	NULL
C.	NULL
Schmalstieg	NULL
,	NULL
J.	NULL
N.	NULL
Thie	NULL
,	NULL
J.	NULL
J.	NULL
O'Shea	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1994	NULL
.	NULL

Interaction	NULL
of	NULL
IL-2R/	NULL
#	NULL
and	NULL
yc	NULL
chains	NULL
with	NULL
Jak1	NULL
and	NULL
Jak3	NULL
:	NULL
Implications	NULL
for	NULL
XSCID	NULL
and	NULL
XCID	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

266:1042-1045	NULL
.	NULL

19	NULL
.	NULL

Miyazaki	NULL
,	NULL
T.	NULL
,	NULL
A.	NULL
Kawahara	NULL
,	NULL
H.	NULL
Fujii	NULL
,	NULL
Y.	NULL
Nakagawa	NULL
,	NULL
Y.	NULL
Minami	NULL
,	NULL
Z.	NULL
J.	NULL
Liu	NULL
,	NULL
I.	NULL
Oishi	NULL
,	NULL
O.	NULL
Silvennoinen	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Witthuhn	NULL
,	NULL
J.	NULL
N.	NULL
Thie	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1994	NULL
.	NULL

Functional	NULL
activation	NULL
of	NULL
Jak1	NULL
and	NULL
Jak3	NULL
by	NULL
selective	NULL
association	NULL
with	NULL
IL-2	NULL
receptor	NULL
subunits	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

266:1045-1047	NULL
.	NULL

20	NULL
.	NULL

Nerenberg	NULL
,	NULL
M.	NULL
I.	NULL
,	NULL
T	NULL
,	NULL
Minor	NULL
,	NULL
J	NULL
.	NULL

Price	NULL
,	NULL
D.	NULL
N.	NULL
Emst	NULL
,	NULL
T.	NULL
Shinohara	NULL
,	NULL
and	NULL
H.	NULL
Schwarz	NULL
.	NULL

1991	NULL
.	NULL

Transgenic	NULL
thymocytes	NULL
are	NULL
refractory	NULL
to	NULL
transformation	NULL
by	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
tax	NULL
gene	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:3349-3353	NULL
.	NULL

21	NULL
.	NULL

Coligan	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
A.	NULL
M.	NULL
Kruisbeek	NULL
,	NULL
D.	NULL
H.	NULL
Margulies	NULL
,	NULL
E.	NULL
M.	NULL
Shevach	NULL
,	NULL
and	NULL
W.	NULL
Strober	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

.	NULL

1991	NULL
.	NULL

In	NULL
Current	NULL
protocols	NULL
in	NULL
immunology	NULL
.	NULL

Greene	NULL
Publishing	NULL
Associates	NULL
and	NULL
Wiley-Interscience	NULL
,	NULL
New	NULL
York	NULL
.	NULL

3.0.5-3.1.5	NULL
.	NULL

22	NULL
.	NULL

Xu	NULL
,	NULL
X.	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

Brown	NULL
,	NULL
I.	NULL
Kitajima	NULL
,	NULL
J.	NULL
Bilakovies	NULL
,	NULL
L.	NULL
W.	NULL
Fey	NULL
,	NULL
and	NULL
M.	NULL
I.	NULL
Nerenberg	NULL
.	NULL

1994	NULL
.	NULL

Transcriptional	NULL
suppression	NULL
of	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
occurs	NULL
by	NULL
an	NULL
unconventional	NULL
interaction	NULL
of	NULL
a	NULL
CREB	NULL
factor	NULL
with	NULL
the	NULL
R	NULL
region	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:5371-5383	NULL
.	NULL

23	NULL
.	NULL

Suzuki	NULL
,	NULL
T.	NULL
,	NULL
J.	NULL
Fujisawa	NULL
,	NULL
M.	NULL
Toita	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
trans-activator	NULL
tax	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-I	NULL
)	NULL
interacts	NULL
with	NULL
cAMP-responsive	NULL
element	NULL
(	NULL
CRE	NULL
)	NULL
binding	NULL
and	NULL
CRE	NULL
modulator	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
21-base-pair	NULL
enhancer	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

90:610-614	NULL
.	NULL

24	NULL
.	NULL

Kitajima	NULL
,	NULL
L.	NULL
,	NULL
T.	NULL
Shinohara	NULL
,	NULL
T.	NULL
Minor	NULL
,	NULL
L.	NULL
Bibbs	NULL
,	NULL
J.	NULL
Bilakovics	NULL
,	NULL
and	NULL
M.	NULL
I.	NULL
Nerenberg	NULL
.	NULL

1992	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
tax	NULL
transformation	NULL
is	NULL
associated	NULL
with	NULL
increased	NULL
uptake	NULL
of	NULL
oligodeoxynucleotides	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:25881-25888	NULL
.	NULL

25	NULL
.	NULL

Damell	NULL
Jr.	NULL
J.	NULL
E.	NULL
,	NULL
I.	NULL
M.	NULL
Kerr	NULL
,	NULL
G.	NULL
R.	NULL
Stark	NULL
.	NULL

1994	NULL
.	NULL

Jak-STAT	NULL
pathways	NULL
and	NULL
transcriptional	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
IFNs	NULL
and	NULL
other	NULL
extracellular	NULL
signaling	NULL
proteins	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

264:1415-1421	NULL
.	NULL

26	NULL
.	NULL

Zhuang	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
S.	NULL
V.	NULL
Patel	NULL
,	NULL
T.	NULL
C.	NULL
He	NULL
,	NULL
S.	NULL
K.	NULL
Sonsteby	NULL
,	NULL
Z.	NULL
Niu	NULL
,	NULL
and	NULL
D.	NULL
M.	NULL
Wojchowski	NULL
.	NULL

1994	NULL
.	NULL

Inhibition	NULL
of	NULL
erythropoietin-induced	NULL
mitogenesis	NULL
by	NULL
a	NULL
kinase-deficient	NULL
form	NULL
of	NULL
Jak2	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:21411-2141	NULL
.	NULL

27	NULL
.	NULL

Muller	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
Briscoe	NULL
,	NULL
C.	NULL
Laxton	NULL
,	NULL
D.	NULL
Guschin	NULL
,	NULL
S.	NULL
Ziemiecki	NULL
,	NULL
O.	NULL
Silvennoinen	NULL
,	NULL
A.	NULL
G.	NULL
Harpur	NULL
,	NULL
G.	NULL
Barbieri	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Witthuhn	NULL
,	NULL
C.	NULL
Schindler	NULL
,	NULL
S.	NULL
Pellegrini	NULL
,	NULL
A.	NULL
F.	NULL
Wilks	NULL
,	NULL
J.	NULL
N.	NULL
Thie	NULL
,	NULL
G.	NULL
R.	NULL
Stark	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Kerr	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
JAK1	NULL
complements	NULL
defects	NULL
in	NULL
interferon-//3	NULL
and	NULL
-y	NULL
signal	NULL
transduction	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

366:129-135	NULL
.	NULL

28	NULL
.	NULL

Velazquez	NULL
,	NULL
L.	NULL
,	NULL
M.	NULL
Fellous	NULL
,	NULL
G.	NULL
R.	NULL
Stark	NULL
,	NULL
and	NULL
S.	NULL
Pellegrini	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
in	NULL
the	NULL
interferon	NULL
//	NULL
signaling	NULL
pathway	NULL
.	NULL

Cell	NULL
.	NULL

70:313-322	NULL
.	NULL

29	NULL
.	NULL

Johnston	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
M.	NULL
Kawamura	NULL
,	NULL
R.	NULL
A.	NULL
Kirken	NULL
,	NULL
Y.	NULL
Q.	NULL
Chen	NULL
,	NULL
T.	NULL
B.	NULL
Blake	NULL
,	NULL
K.	NULL
Shibuya	NULL
,	NULL
J.	NULL
R.	NULL
Ortaldo	NULL
,	NULL
D.	NULL
W.	NULL
McVIcar	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
O'Shea	NULL
.	NULL

1994	NULL
.	NULL

Phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
the	NULL
Jak-3	NULL
Janus	NULL
kinase	NULL
in	NULL
response	NULL
to	NULL
interleukin-2	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

370:151-153	NULL
.	NULL

30	NULL
.	NULL

Dendofer	NULL
,	NULL
U.	NULL
,	NULL
P.	NULL
Oettgen	NULL
,	NULL
and	NULL
T.	NULL
A.	NULL
Libermann	NULL
.	NULL

1994	NULL
.	NULL

Multiple	NULL
regulation	NULL
elements	NULL
in	NULL
the	NULL
interleukin-6	NULL
gene	NULL
mediate	NULL
induction	NULL
by	NULL
prostaglandins	NULL
,	NULL
cyclic	NULL
AMP	NULL
,	NULL
and	NULL
lipopolysacharide	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:4443-4454	NULL
.	NULL

31	NULL
.	NULL

Brown	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
X.	NULL
Xu	NULL
,	NULL
I.	NULL
Kitajima	NULL
,	NULL
T.	NULL
Shinohara	NULL
,	NULL
J.	NULL
Bilakovics	NULL
,	NULL
T.	NULL
Shiner	NULL
,	NULL
and	NULL
M.	NULL
I.	NULL
Nerenberg	NULL
.	NULL

1994	NULL
.	NULL

Genomic	NULL
footprinting	NULL
of	NULL
the	NULL
human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
in	NULL
a	NULL
transgenic	NULL
mouse	NULL
tumorigenesis	NULL
model	NULL
.	NULL

Transgenics	NULL
.	NULL

1:377-393	NULL
.	NULL

32	NULL
.	NULL

Taniguchi	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Y.	NULL
Minami	NULL
.	NULL

1993.	NULL
the	NULL
IL-2/IL-2	NULL
receptor	NULL
system	NULL
:	NULL
a	NULL
current	NULL
overview	NULL
.	NULL

Cell	NULL
.	NULL

73:5-8	NULL
.	NULL

33	NULL
.	NULL

Siekevitz	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
B.	NULL
Feinberg	NULL
,	NULL
N.	NULL
Holbrook	NULL
,	NULL
F.	NULL
Wong-Staal	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1987	NULL
.	NULL

Activation	NULL
of	NULL
interleukin	NULL
2	NULL
and	NULL
interleukin	NULL
2	NULL
receptor	NULL
(	NULL
Tac	NULL
)	NULL
promoter	NULL
expression	NULL
by	NULL
the	NULL
trans-activator	NULL
(	NULL
tat	NULL
)	NULL
gene	NULL
product	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
Type	NULL
1	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

84:5389-5393	NULL
.	NULL

34	NULL
.	NULL

Sugamura	NULL
,	NULL
K.	NULL
,	NULL
K.	NULL
Ohbo	NULL
,	NULL
N.	NULL
Takazawa	NULL
,	NULL
and	NULL
M.	NULL
Nakamura	NULL
.	NULL

1994	NULL
.	NULL

Regulation	NULL
of	NULL
IL-2	NULL
receptor	NULL
subunit	NULL
expression	NULL
in	NULL
HTLV-1	NULL
infected	NULL
T	NULL
cells	NULL
.	NULL

AIDS	NULL
Res	NULL
.	NULL

Hum	NULL
.	NULL

Retroviruses	NULL
(	NULL
abstract	NULL
)	NULL
10	NULL
(	NULL
supl	NULL
)	NULL
:	NULL
$	NULL
74	NULL
.	NULL

35	NULL
.	NULL

Leonard	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
J.	NULL
M.	NULL
Depper	NULL
,	NULL
R.	NULL
J.	NULL
Robb	NULL
,	NULL
T.	NULL
A.	NULL
Waldmann	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Green	NULL
.	NULL

1983	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
human	NULL
receptor	NULL
for	NULL
T-cell	NULL
growth	NULL
factor	NULL
.	NULL

Proc	NULL
.	NULL

Nat	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

80:6957-6961	NULL
.	NULL

36	NULL
.	NULL

Taniguchi	NULL
,	NULL
T.	NULL
1988	NULL
.	NULL

Regulation	NULL
of	NULL
cytokine	NULL
gene	NULL
expression	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

6:439-464	NULL
.	NULL

37	NULL
.	NULL

Boulton	NULL
,	NULL
T.	NULL
G.	NULL
,	NULL
N.	NULL
Stahl	NULL
,	NULL
and	NULL
G.	NULL
D.	NULL
Yancopoulos	NULL
,	NULL
1994	NULL
.	NULL

Ciliary	NULL
neuro-trophic	NULL
factor/leukemia	NULL
inhibitory	NULL
factor/interleukin	NULL
6/oncostain	NULL
M	NULL
family	NULL
of	NULL
cytokines	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
a	NULL
common	NULL
set	NULL
of	NULL
proteins	NULL
overlapping	NULL
those	NULL
induced	NULL
by	NULL
other	NULL
cytokines	NULL
and	NULL
growth	NULL
factors	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:11648-11655	NULL
.	NULL

38	NULL
.	NULL

Matsuda	NULL
,	NULL
T.	NULL
,	NULL
Y.	NULL
Yamanaka	NULL
,	NULL
and	NULL
T.	NULL
Hirano	NULL
.	NULL

1994	NULL
.	NULL

Interleukin-6	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
multiple	NULL
proteins	NULL
in	NULL
murine	NULL
hematopoietic	NULL
lineage	NULL
cells	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

200:821-828	NULL
.	NULL

39	NULL
.	NULL

Franchini	NULL
,	NULL
G.	NULL
,	NULL
J.	NULL
C.	NULL
Mulloy	NULL
,	NULL
I.	NULL
J.	NULL
Koralnik	NULL
,	NULL
A	NULL
.	NULL

Lo	NULL
Monico	NULL
,	NULL
J.	NULL
J.	NULL
Sparkowski	NULL
,	NULL
T.	NULL
Andresson	NULL
,	NULL
D.	NULL
J.	NULL
Goldstein	NULL
,	NULL
and	NULL
R.	NULL
Schlegel	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
human	NULL
T-cell	NULL
leukemia/	NULL
lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
p12I	NULL
protein	NULL
cooperates	NULL
with	NULL
the	NULL
E5	NULL
oncoprotein	NULL
of	NULL
bovine	NULL
papillomavirus	NULL
in	NULL
cell	NULL
transformation	NULL
and	NULL
binds	NULL
the	NULL
16-kilodalton	NULL
subunit	NULL
of	NULL
the	NULL
vacuolar	NULL
H*	NULL
ATPase	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:7701-7704	NULL
.	NULL

40	NULL
.	NULL

Koralnik	NULL
1J	NULL
.	NULL

,	NULL
J.	NULL
Fullen	NULL
,	NULL
G.	NULL
Franchini	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
p121	NULL
,	NULL
P13II	NULL
,	NULL
and	NULL
p3OII	NULL
proteins	NULL
encoded	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia/lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
open	NULL
reading	NULL
frames	NULL
I	NULL
and	NULL
II	NULL
are	NULL
localized	NULL
in	NULL
three	NULL
different	NULL
cellular	NULL
compartments	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:2360-2366	NULL
.	NULL

41	NULL
.	NULL

Grabstein	NULL
,	NULL
K.	NULL
H.	NULL
,	NULL
J.	NULL
Eisenman	NULL
,	NULL
K.	NULL
Shanebeck	NULL
,	NULL
C.	NULL
Rauch	NULL
,	NULL
S.	NULL
Srinivasan	NULL
,	NULL
V.	NULL
Fung	NULL
,	NULL
C.	NULL
Beers	NULL
,	NULL
J.	NULL
Richardson	NULL
,	NULL
M.	NULL
A.	NULL
Schoenborn	NULL
,	NULL
M.	NULL
Ahdieh	NULL
,	NULL
L.	NULL
Joshson	NULL
,	NULL
M.	NULL
R.	NULL
Anderson	NULL
,	NULL
J.	NULL
D.	NULL
Watson	NULL
,	NULL
D.	NULL
M.	NULL
Anderson	NULL
,	NULL
and	NULL
J.	NULL
G.	NULL
Giri	NULL
.	NULL

1994	NULL
.	NULL

Cloning	NULL
of	NULL
a	NULL
T	NULL
cell	NULL
growth	NULL
factor	NULL
that	NULL
interacts	NULL
with	NULL
the	NULL
3	NULL
chain	NULL
of	NULL
the	NULL
interleukin	NULL
receptor	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

264:965-968	NULL
.	NULL

42	NULL
.	NULL

Giri	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
M.	NULL
Ahdieh	NULL
,	NULL
J.	NULL
Eisenman	NULL
,	NULL
K.	NULL
Shanebeck	NULL
,	NULL
K.	NULL
Grabstein	NULL
,	NULL
S.	NULL
Kumaki	NULL
,	NULL
A.	NULL
Namen	NULL
,	NULL
L.	NULL
$	NULL
.	NULL

Park	NULL
,	NULL
D.	NULL
Cosman	NULL
,	NULL
and	NULL
D.	NULL
Anderson	NULL
.	NULL

1994	NULL
.	NULL

Utilization	NULL
of	NULL
the	NULL
3	NULL
and	NULL
y	NULL
chains	NULL
of	NULL
the	NULL
IL-2	NULL
receptor	NULL
by	NULL
the	NULL
novel	NULL
cytokine	NULL
IL-15	NULL
.	NULL

EMBO	NULL
{	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
13:2822-2830	NULL
.	NULL

Constitutive	NULL
Jak	NULL
Activation	NULL
by	NULL
HTLV-1	NULL
QTax	NULL
and	NULL
Virus	NULL
1555	NULL

